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I. ABSTRACT 
Tuberculosis is an emergency disease worldwide, the emergence of resistant strains to the 
treatment has produced the use of natural products as alternative. Studies have shown that 
Leucophyllum frutescens extracts present antimicrobial effect, but the disadvantage is that 
the extracts are recovered in a vehicle that contains organic solvents. The preparation of 
polymeric nanoparticles (NP) involves the elimination of the solvent in which the active 
is solubilized, which makes possible to use them as vehicles for the administration of the 
extracts. Therefore, the aim of this study was to design and develop formulations of NP 
with an extract of L. frutescens, and rifampicin (RIF), in order to evaluate the in vitro 
biological activity against M. tuberculosis. Firstly, the methanolic extract of leaves and 
roots of L. frutescens and its fractions were obtained. The anti-M. tuberculosis activity 
was determined, being the root extract (EMR) and its hexane fractions (FHR and RF1) the 
most actives with a MIC of 100, 40 and 40 ȝg/mL, respectively. RIF, EMH, FHR and RF1 
were incorporated into NP by nanoprecipitation. NP of ≈180 nm with homogeneous size 
distribution were obtained. The NP were evaluated on M. tuberculosis, being the 
formulation of NP-PLGA-RIF (MIC=0.10 ȝg/mL) and NP-PLGA-RF1 (CMI=80 ȝg/mL) 
with better activity. Finally, the anti-M. tuberculosis activity of the combined form 
formulations was evaluated, the combination of RIF with NP-PLGA-RF1 produced better 
behavior, reducing the MIC of both without showing toxic effect. The studies carried out 
in this work showed the potential use of an NP formulation contains a vegetable fraction 
of  L. frutescens in combination with RIF as an alternative against M. tuberculosis. 
 
II. RÉSUMÉ 
La tuberculose est une maladie d'urgence dans le monde, l'apparition de souches 
résistantes au traitement a produit l'utilisation de produits naturels comme alternative. Des 
études ont montré que les extraits de Leucophyllum frutescens présentaient un effet 
antimicrobien, mais l'inconvénient est que les extraits sont récupérés dans un véhicule qui 
contient des solvants organiques. La préparation de nanoparticules polymériques (NP) 
implique l'élimination du solvant dans lequel l'actif est solubilisé, ce qui permet les utiliser 
comme véhicules pour l'administration des extraits. Par conséquent, le but de cette étude 
a été design et développer des formulations de NP avec un extrait de      L. frutescens et 
de la rifampicine (RIF), afin d'évaluer l'activité biologique in vitro contre M. tuberculosis. 
Premièrement, l'extrait méthanolique de feuilles et de racines de L. frutescens et ses 
fractions a été obtenu. L'activité contre M. tuberculosis a été déterminée, l'extrait de 
racines (EMR) et ses fractions hexanique (FHR et RF1) ont été les plus actives avec une 
CMI de 100, 40 et 40 ȝg/mL, respectivement. RIF, EMH, FHR et RF1 ont été incorporés 
dans NP par nanoprécipitation. Des NP de ≈180 nm avec une distribution de taille 
homogène ont été obtenus. Les NP ont été évaluées sur M. tuberculosis, les formulations 
de NP-PLGA-RIF (CMI=0,10 ȝg/mL) et NP-PLGA-RF1 (CMI=80 ȝg/mL) ont montré la 
meilleure activité. Finalement, l'activité des formulations combinées contre M. 
tuberculosis a été évaluée, la combinaison de RIF avec NP-PLGA-RF1 a produit le 
meilleur comportement, réduisant la CMI des deux sans montrer un effet toxique. Les 
études réalisées dans ce travail ont montré l'utilisation potentielle d'une formulation de NP 
contient une fraction végétale de L. frutescens en combinaison avec le RIF comme 
alternative contre M. tuberculosis. 
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III. INTRODUCTION 
 
1. Tuberculosis 
Tuberculosis (Tb) is an infectious disease caused by Mycobacterium tuberculosis 
(OMS, 2018), which is an acid-fast bacillus. It particularly affects the lungs, developing 
pulmonary Tb (Ruiz-Manzano et al., 2008). Since 1993, it is considered by the World 
Health Organization (WHO) as an emergency disease worldwide. In 2016, 10.4 million 
people became ill with tuberculosis and 1.7 million died from this disease (OMS, 2018). 
The current therapeutic scheme against Tb is based on the administration of four first-
line antibiotics: isoniazid (INH), rifampicin (RIF), pyrazinamide (PZA) and streptomycin 
or ethambutol, for 6 months (WHO, 2005). Specifically, RIF is the only bactericidal drug 
that has activity on different populations that the bacteria present in the organism.  
One limitation of the treatment is that, due to its long duration many patients do not 
follow it adequately, which causes the appearance of drug-resistant strains. Therefore, to 
improve the pharmacological therapy and evade the resistance of the agent, it is urgent to 
find alternatives that reduce the time of treatment, or substances with a mechanism of 
action different to the existing drugs. 
 
2. Natural Products 
The plants have been used in traditional medicine to treat several diseases. WHO 
estimates that in many developed countries, from 70 to 80% of the population has resorted 
once to some form of alternative or complementary medicine (OMS, 2008).   
Research in natural products has grown in recent years, numerous medicinal plant 
compounds that exhibit bioactivity have been described, including antimycobacterial 
activity (Camacho-Corona et al., 2009). 
For this reason and in response to the urgency of obtaining new drugs against strains 
of M. tuberculosis, several studies based on natural products have been developed. Some 
plants of the north of Mexico have been evaluated with favorable activity, among them, 
extracts of Leucophyllum frutescens, commonly named “cenizo”. 
In the study by Molina-Salinas et al., extracts of L. frutescens against drug-resistant 
and drug-resistant strains of M. tuberculosis were tested. The extract of the leaves and 
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roots were obtained by maceration. The evaluation by microdilution in broth showed an 
activity of the root extract of 62.5 ȝg/mL, for the sensitive and the resistant strain. For the 
leaves, a MIC of 125 ȝg/mL was obtained. This study supports that, the selection of plants 
by ethnobotanical criteria increases the possibility of finding species with activity, not 
only against M. tuberculosis, but also against other microorganisms (Molina-Salinas et 
al., 2007).  
However, the disadvantage of the use of extracts is that they are recovered in vehicles 
containing organic solvents, therefore their application in vivo is not viable. 
To overcome these limitations, new strategies have been proposed, including the use 
of polymeric nanoparticles (NP) as a vehicle for the administration of plant extracts. 
 
3. Polymeric nanoparticles 
NP (Figure 1) are particles of less than 500 nm in diameter that are prepared from 
natural or synthetic, biodegradable or non-biodegradable polymers. Drugs, proteins, 
peptides or nucleotides can be incorporated into these polymeric systems for their 
therapeutic application. 
 
 
Figure 1. Structure of polymeric nanoparticles. 
 
Among the features that stand out from these colloidal systems include the protection 
of the active, the targeting to an organ or cell and the sustained release of the encapsulated 
compound (Martínez Rivas et al., 2017), this last virtue allows to reduce the frequency of 
treatment dose. On the other hand, the preparation of NP involves the elimination of the 
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solvent in which the active is solubilized (Figure 2), resulting in the encapsulation of the 
active compounds, free of organic solvents. 
An additional advantage of NP is related to the versatility in their administration, 
depending their composition. NP can be applied topically (Martínez Rivas et al., 2017), 
oral or parenteral (Pilheu et.al., 2007). 
Therefore, it is important to note that NP are a potential vehicle to increase the 
antimycobacterial activity of drugs used in the treatment of tuberculosis and to transport 
natural extracts that can not be administered directly to the body. 
 
 
Figure 2. Preparation of polymeric nanoparticles by nanoprecipitation. 
 
4. Encapsulation of natural compounds in polymeric nanoparticles  
In recent years the interest in the encapsulation of plant extracts or derivatives has 
increased. An example of this, is the encapsulation of resveratrol. Yao et al. incorporated 
the compound in chitosan NP with free amino groups on the surface. NP had a particle 
size of 487 nm and an polydispersity index of 0.144; in addition, chitosan NP showed 
sustained release in vitro (Yao et al., 2006).  
In another study, Uthaman et al. extracted boswellic acid from the rubber resin of 
Boswellia serrata. The volumetric analysis showed a total of boswellic acid in the extract 
of 60%. Subsequently, formulations of NP were formulated with boswellic acid by 
nanoprecipitation method. NP had a diameter of 259 nm and a Z potential of -42.88 mV. 
In vitro cytotoxicity assays were performed with different cancer cell lines (pancreas, 
brain, prostate and melanoma). The PC3 prostate cancer cell line showed favorable 
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cytotoxicity percentages. Therefore, they concluded that NP formulations containing 
boswellic acid can be used as potential anticancer agents in the treatment of prostate 
cancer (Uthaman et al., 2012). 
 
5. Drugs for the treatment of tuberculosis loaded in polymeric nanoparticles 
Different studies have verified the protective properties (Calleja-Avellanal et al., 
2003), targeting (Yolandy et al., 2010) and sustained release (Maksimenko et al., 2010) 
from NP containing first-line drugs of the tuberculosis treatment, including RIF. NP 
improved the bioavailability of the drugs and reduced the frequency of the dose (Pandey 
et al., 2003; Pandey y Khuller, 2006). In addition, there are several works that showed an 
effect against M. tuberculosis when they are encapsulated in NP. An example was 
observed in the study conducted by Yolandy et al., who demonstrated targeting of 
isoniazid (INH) in nanoparticulate delivery systems. In vitro tests were performed on 
THP-1 and U937 monocyte-macrophages and microscopic analysis showed that targeting 
was achieved. After 1 and 2 days of exposure of INH loaded NP, a significant inhibition 
in the growth of the microorganism was observed, but with a reduced value in the 
toxicity/efficiency ratio compared with free INH (Yolandy et al., 2010). And, Booysen et 
al. proved that RIF and INH loaded NP have activity against the strain of M. tuberculosis 
H37Rv. In addition, they carried out the oral administration of the formulations in mice 
and observed a sustained release of the drugs for 7 days. They also determined the 
distribution of RIF and INH in the liver and the lungs for up to 10 days. With these results, 
they conclude that NP containing drugs for the treatment of tuberculosis have the potential 
to improve Tb chemotherapy (Booysen et al., 2013). 
Therefore, the incorporation of plant compounds in NP as well as a first-line drug such 
as RIF is a promising alternative. In this context, the present work focused on the 
encapsulation of the extract and the fractions of L. frutescens in NP to generate a 
phytomedicine, as well as the incorporation of RIF, with the purpose of improving the 
activity against M. tuberculosis, and thus, proposing them as treatment for tuberculosis. 
 
 
 
 5 
 
IV. JUSTIFICATION 
 
Tb is considered since 1993, by WHO, a worldwide emergency disease. One of the 
main causes of the great number of deaths, reported each year because of this disease, is 
due to the resistance that the bacillus strains have acquired in consequence to the 
inadequate monitoring of the treatment. 
For this reason, it is urgent to find alternatives that reduce the treatment time and 
actives with a mechanism of action different from the existing drugs, to treat resistant 
strains. In recent years, natural products have been studied for the molecules with 
biological activity it contains, but their application is limited to the presence of organic 
solvents with which extracts are recovered. 
NP are a vehicle of biologically active compounds that offers multiple advantages, 
among them, the removal of the organic solvents in which the active compounds are 
dissolved. Therefore, the incorporation of plant compounds in NP is a promising 
alternative. In addition, NP provide sustained release to the encapsulated compound, 
making possible to reduce the dose frequency. 
In this context, the present work is focused on incorporation of extracts and fractions 
of Leucophyllum frutescens plant to generate a phytomedicine, as well as encapsulation 
of RIF, in order to enhance the activity against M. tuberculosis and propose them as 
treatment for Tb. 
 
V. HYPOTHESIS  
 
The encapsulation of an extract or fraction of L. frutescens and rifampicin in polymeric 
nanoparticles allows the enhancement of the activity against M. tuberculosis. 
 
VI. GENERAL OBJECTIVE 
 
To design and develop NP formulations based on an extract or fraction of L. frutescens 
and RIF, in order to increase their biological activities against M. tuberculosis. 
 
 6 
 
VII. SPECIFIC OBJECTIVES 
 
o To obtain the methanol extracts of leaves and roots of L. frutescens by maceration 
and sonication and carry out the fractionation. 
 
o To develop a chromatographic method validated by CLAR in order to characterize 
the extracts and their fractions and obtain their chromatographic profiles. 
 
o To encapsulate the extracts and active fractions by nanoprecipitation technique in 
NP and perform their physicochemical characterizations according to the size, 
polydispersity index (PDI), zeta potential, surface morphology, drug loading and 
encapsulation efficiency. 
 
o To encapsulate RIF in NP by nanoprecipitation technique and perform their 
physicochemical characterizations according to the size, PDI, zeta potential, 
surface morphology and incorporated compounds. 
 
o To evaluate the in vitro biological activity of the NP formulations on M. 
tuberculosis, as well as to determine the synergistic effect of the drug and the 
vegetable samples, free and encapsulated. 
 
o To evaluate the toxicity of NP formulations with better antimycobacterial 
activities. 
 
 
 
 
 
 
 
 7 
 
CHAPTER 1. RIFAMPICIN AND Leucophyllum frutescens: 
ENCAPSULATION IN BIODEGRADABLE POLYMERIC 
NANOPARTICLES AND THEIR BIOLOGICAL EVALUATION 
AGAINST Mycobacterium tuberculosis 
 
ABSRACT 
Tuberculosis (Tb), is an emergency disease worldwide, caused by Mycobacterium 
tuberculosis. For its treatment four first-line drugs are administered; however, the 
emergence of resistant strains has led to the promising use of natural products as an 
alternative to combat the disease. Studies show that several plant extracts have action 
against M. tuberculosis, such as Leucophyllum frutescens. The disadvantage of the 
extracts is that they are recovered in vehicles as organic solvents, which makes difficult 
its application in vivo. The preparation of polymeric nanoparticles (NP) involves the 
elimination of the solvent in which the active is solubilized, it makes possible to use them 
as vehicles for the administration of extracts. While, RIF an antibiotic used in the 
treatment, is a model for the incorporation in NP. The objective of the present work was 
to formulate NP with the extract and fractions of L. frutescens and to evaluate its activity 
against M. tuberculosis in order to propose its use as a coadjuvant of the antituberculosis 
drug RIF. In parallel, a formulation of RIF loaded NP was developed with the aim of 
improving the therapeutic performance of the drug. Firstly, chromatographic profile of 
methanol extracts of leaves and roots and their fractions of L. frutescens were obtained by 
HPLC. For leaves, four peaks-components were appreciated, for roots seven peaks-
components were appreciated. The screening of methanol extracts of leaves and roots and 
their fractions for anti-M. tuberculosis activity revealed that the best activities were shown 
with the extract of roots (EMR) and the hexane fractions (FHR and RF1) with a MIC=100, 
40 and 40 ȝg/mL, respectively. Subsequently, EMR, FHR, RF1 and RIF were 
encapsulated. NP had sizes between 140 and 190 nm, with homogeneous distributions and 
negative zeta potential. Then, the formulations were tested on M. tuberculosis. The 
formulation of RIF with the best activity was PLGA-PVAL-NP with a MIC of 0.10 ȝg/mL 
compared with the free drug that showed a MIC of 0.20 ȝg/mL. While, among the 
vegetable samples, were the formulations of FHR-PLGA-NP and RF1-PLGA-NP which 
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presented the best activities with a MIC of 80 ȝg/mL for both. An assay combining free 
actives and formulations and were carried out. The combination of RIF and RF1-PLGA-
NP reduced the MIC for both cases. Finally, the toxicity was measured by hemolysis, the 
results showed that EMR, FHR, RF1 free and formulated produced hemolysis but there is 
no presence of hemolysis with the combination of RIF and RF1-PLGA-NP. In this study, 
NP formulations containing RIF, active extract or active fractions of L. frutescens against 
M. tuberculosis were developed, finding promising the use of RF1-PLGA-NP as 
coadjuvant of the antituberculosis drug RIF. 
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INTRODUCTION 
Tuberculosis (Tb), since 1993, is considered by the World Health Organization as an 
emergency disease worldwide. In 2016, 10.4 million people became ill with tuberculosis 
and 1.7 million died (OMS, 2018). Four first-line antibiotics are administered to treat the 
disease, including rifampicin (RIF). However, the daily administration of the drugs for 
more than 6 months orally (NOM NOM-006-SSA2-1993). 
One limitation of the treatment is its long duration, patients do not follow it adequately, 
which causes the appearance of resistant strains to the drugs. Therefore, to improve drug 
therapy and to evade the resistance of the agent, it is urgent to find alternatives that reduce 
the time of treatment or find substances with a different mechanism of action from the 
existing drugs. 
Plants have been used in traditional medicine to treat different diseases. WHO 
estimates that 70 to 80% of the population has ever resorted to one or another form of 
alternative or complementary medicine (OMS, 2008). The phytochemical study has 
grown in recent years and have been described numerous compounds obtained from 
medicinal plants that exhibit biological activity, including antimycobacterial activity 
described (Camacho-Corona et al., 2009). 
For this reason, and in response to the urgency of obtaining new treatments against M. 
tuberculosis strains, natural products studies have been developed. Several plants in 
northern of Mexico have a favorable activity against this bacterium. Particularly, the 
extracts of L. frutescens plant, commonly known as “cenizo”, were found among those 
that presents best activity. 
Molina-Salinas et al., evaluated the methanol extract from leaves and roots of L. 
frutescens on the sensitive and multi-drug resistant strain of M. tuberculosis. Leaves 
extract had no activity on the sensitive strain, whereas, in the resistant multi-drug strain 
showed a MIC of 125 µg/mL. Roots extract had a MIC of 62.5 µg/mL in both strains 
(Molina-Salinas et al., 2007). 
However, the disadvantage of this type of extracts is they are recovered in vehicles 
that contain organic solvents, thus their application in vivo is not viable. To overcome this 
limitation, new strategies have been proposed such as polymeric nanoparticles (NP) use. 
NP are systems that present sustained release allowing the reduction of the frequency of 
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treatment doses; in addition, NP confer to the active: protection (Yoo et al., 2011), 
targeting to specific tissues and controlled delivery (Maksimenko et al., 2010; Pandey y 
Khuller, 2006). For example, Yao et al., carried out studies about the release of resveratrol 
(a compound present in grapes) incorporated in chitosan nanoparticles, the results showed 
that the nanoparticles had a sustained release and, therefore, a reduction in the frequency 
of the dose (Yao et al., 2006).   
Antitubercular drugs have also been incorporated in NP for the enhancement of their 
activities. Booysen et. al. encapsulated RIF and isoniazid (INH) in polylactic-co-glycolic 
acid (PLGA) NP covered with polyethylene glycol (PEG) by the double emulsion 
technique and spray drying. They obtained nanoparticle sizes from 230 to 380 nm with 
zeta potentials of +12.45mV and the encapsulation efficiencies for RIF and INH were 
68.48 and 55.2%, respectively. In addition, they proved that RIF loaded NP had activity 
against the strain of M. tuberculosis H37Rv. On the other hand, they carried out the oral 
administration of a dose of the formulations in mice and observed a sustained release of 
the drugs for 7 days and biodistribution of RIF in the liver and INH in the lungs after 10 
days. With these results, they concluded that PLGA NP containing antituberculosis 
drugs have the potential to improve Tb therapy (Booysen et al., 2013). For this reason, 
RIF being an antibiotic used in the treatment of Tb, is a model drug for its incorporation 
into NP. 
The promising use of extracts or fractions is accompanied by the term 
biocompatibility. Two aspects that should be considered in the study of sample 
compatibility are: cytotoxicity and hemocompatibility. Knowing this last aspect, extracts 
or non-toxic fractions can be proposed for the use in an organism. 
The aim of the present work was to take advantage of anti-M. tuberculosis activity that 
presents the extracts and fractions from L. frutescens plant to formulate them in NP in 
order to make viable its application against M. tuberculosis. In addition, the combined 
effect of extracts and fractions free and encapsulated was evaluated to propose the use of 
an extract or fraction of L. frutescens as coadjuvant of the antituberculosis drug RIF. 
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MATERIALS AND METHODS 
 
Preparation of Leucophyllum frutescens extracts and their fractions  
Leaves and roots of L. frutescens were collected in Monterrey, N. L., Mexico in 
July 2013. Consequently, the plant material was washed, dried at room temperature and 
pulverized. 50 g of powdered leaves or roots were weighed, 350 mL of methanol was 
added. The extracts were obtained by ultrasound (Ultrasonic Cleaners, VWR Symphony, 
USA). For a period of 1 h, the temperature for the extraction was increased from 25 to 60 
ºC, once reached 60 ºC, three cycles of 10 min of sonication and 10 min of rest were 
performed. Subsequently, the samples were filtered to obtain the solvent, which was 
evaporated under reduced pressure (Laborota 4003 control, Heidolph) in order to obtain 
the methanol extract of leaves (EMH) and roots (EMR). 
With respect to the fractionation of the extracts, two methods were used. In the 
method 1, EMH was solubilized in methanol, it was placed in a separatory funnel and 
hexane was added; subsequently, both solvents were mixed and the hexane part was 
recovered and evaporated under reduced pressure in order to obtain the hexane fraction 
(FHH). The same procedure was followed with the EMR in order to obtain the hexane 
fraction from roots (FHR). 
In the method 2, hexane was added to the EMH and stirred to aid the solubilization 
of the compounds related to the solvent, then, it was filtered to obtain the solvent and 
evaporated obtaining the hexane fraction called HF1. Chloroform was added to the solid 
insoluble in hexane, stirred, filtered to obtain the solvent with the compounds related to 
chloroform and evaporated obtaining the chloroformic fraction (HF2). This procedure was 
repeated with other solvents of higher polarity (ethyl acetate, ethanol and methanol) in 
order to obtain the HF3-HF5 fractions. 
The fractionation method 2 was also performed to the EMR, identifying the 
obtained fractions as RF1-RF5. The yield (%) of the extracts and the fractions were 
calculated according to equations 1 and 2, respectively: 
 Yield of the extract ሺ%ሻ = �೐�೟ೝ��೟�೛೗�೙೟  ܺ ͳͲͲ         ሺͳሻ           
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Yield of the fraction ሺ%ሻ = �೑ೝ��೟�೚೙�೐�೟ೝ��೟  ܺ ͳͲͲ      ሺʹሻ      
 
where, Wextract is the weight (g) of the obtained extract once the solvent is evaporated, 
Wplant is the weight (g) of the dried and powdered leaves or roots, Wfraction is the weught 
(g) of the obtained fraction once the solvent is evaporated, and Wextract is the weight (g) of 
the extract for the fractionation.  
 
Chromatographic analysis of the extracts and fractions of Leucophyllum frutescens 
For the obtaining of the chromatographic profile of the EMH, EMR and fractions, 
the samples were dissolved separately in acetonitrile (J. T. Baker, USA)/methanol (Tedia, 
USA), each solution was filtered through a 0.45 ȝm filter (Millipore, USA) to be analyzed 
by HPLC (VARIAN 9065, 9012, ProStar 410, USA). A Synergi™ 4 ȝm Fusion-RP 80 Å 
(150 mm x 2.0 mm x 4 ȝm) column, a flow of 0.2 mL/min and 30 °C was used. The mobile 
phase was formic acid (purity: 90%, Millipore, USA) at 0.1% v/v and methanol with an 
isocratic elution of 45:55 for 40 min for leaves and 60 min for roots. The profiles were 
detected at Ȝ=215 nm. 
 
Chromatographic analysis of rifampicin  
The RIF analysis (Sigma-Aldrich, USA) was carried out by HPLC using a Zorbax 
Eclipse XDB-C18 (150 mm x 2.1 mm x 5 µm) column, with a mobile phase formed by 
acetonitrile and water at 0.1% v/v of formic acid with an isocratic elution of 60:40 with a 
flow of 0.35 mL/min at 30 °C and at Ȝ=334 nm. 
 
Preparation of the calibration curve and method validation for the quantification of 
rifampicin  
For the quantification of RIF a stock solution in acetonitrile was prepared. From 
this solution, the working solutions were prepared in a range from 5 to γ0 ȝg/mL and 
filtered through a 0.45 ȝm membrane. The analysis was carried out by HPLC to obtain 
the calibration curve. 
The chromatographic method was validated through the variables: linearity, limit 
of detection (LOD) and limit of quantification (LOQ) according to the International 
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Conference on Harmonization (ICH). For the establishment of the linearity, the calibration 
curve was prepared and analyzed in triplicate. The LOD and LOQ were calculated by the 
following equations: 
 Limit of detection ሺLODሻ = ͵.͵ �ܵ                 ሺ͵ሻ 
 Limit of quantification ሺLOQሻ = ͳͲ �ܵ         ሺͶሻ 
 
where, � is the standard deviation of the response and S is the slope of the calibration 
curve.    
The repeatability was established with three levels of concentration, six times each 
one the same day, while the reproducibility was obtained with three levels of 
concentration, six times each one in two different days. 
 
Preparation of the calibration curve of the methanol extract from roots and their 
hexane fractions of Leucophyllum frutescens 
For the quantification of the plant samples in NP, calibration curves of the EMR, 
FHR and RF1 were prepared. The samples were prepared in a mixture of 
acetonitrile/methanol at a concentration of 600 – 1700 ȝg/mL, the solution was filtered 
through a 0.45 ȝm filter to be analyzed by HPLC. 
Synergi™ 4 ȝm Fusion-RP 80 Å (150 mm x 2.0 mm x 4 ȝm) column was used. 
The mobile phase was formic acid at 0.1% v/v and methanol in an isocratic elution of 
45:55 for 60 min with a flow of 0.2 mL/min, 30 ºC and at Ȝ=220 nm. 
The chromatographic method for the sample RF1 was validated through the 
variables: linearity, LOD and LOQ according to the ICH. 
 
Encapsulation and characterization of rifampicin, methanol extract and hexanic 
fractions of Leucophyllum frutescens roots in biodegradable polymeric nanoparticles 
 Four different formulations of RIF loaded NP were prepared by the 
nanoprecipitation technique proposed by Fessi et al. (Fessi et al., 1989). Briefly, the 
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organic phase was prepared containing polylactic acid (PLA; PURASORB) or polylactic-
co-glycolic acid (PLGA; MEDISORB 85 15 DL) and 2 mg of RIF in 3 mL of a mixture 
of solvents (acetone:methanol). The organic phase was added to 10 mL of an aqueous 
phase, containing polyvinyl alcohol (PVAL) (Clariant, Mexico) or Lutrol F127 (BASF) 
as a tensoactive agent at a concentration of 1% (w/w). 
Then, the organic solvent was evaporated under reduced pressure. In this way, four 
formulations of RIF loaded NP were obtained. The NP characterization was carried out 
determining the particle size and polydispersity index (PDI) by dynamic light scattering 
(Zetasizer Nano ZS90, Malvern Instruments, UK). The zeta potential was measured by 
electrophoretic light scattering (Zetasizer Nano ZS90, Malvern Instruments, UK). 
Two different formulations EMR, FHR or RF1 in NP were prepared by the 
nanoprecipitation technique. The organic phase was prepared with the particle-forming 
polymer, 20 mg of PLA or 15 mg of PLGA, and the plant sample (8 mg for EMR or 4 mg 
for FHR or RF1) in solvent mixture (acetone: methanol). The organic phase was added to 
PVAL at 1% w/w in constant stirring. The NP characterization was carried out by 
determining the particle size, PDI and zeta potential. 
To determine the drug loading and encapsulation efficiency (%L and %EE), the 
NP formulations were centrifuged at 25,000 rpm (Allegra 64R, Beckman Coulter, USA), 
the supernatant was decanted, and the pellets were lyophilized (Freeze Dry System, 
LABCONCO, USA). The lyophilized NPwere dissolved in acetonitrile for NP-RIF and 
acetonitrile:methanol for NP-EMR, NP-FHR and NP-RF1. 
 The obtained solutions were analyzed according to the chromatographic method 
previously described to quantify the samples from the calibration curves of each one. 
Subsequently, the %L and % EE for each formulation were determined by the following 
equations: 
 Drug loading ሺ%Lሻ = ܹ݁�݃ℎ� ݋݂ �ℎ݁ �ܿ���݁ �݊ ��ܹ݁�݃ℎ� ݋݂ �ℎ݁ �� ݌݈݈݁݁�   ܺͳͲͲ  ሺͷሻ 
 Encapsulation efficiency ሺ%EEሻ = ܹ݁�݃ℎ� ݋݂ �ℎ݁ �ܿ���݁ �݊ ��ܹ�݃ℎ� ݋݂ ܴ��   ܺͳͲͲ  ሺ͸ሻ 
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All the analyzes were carried out in triplicate, only the analysis of NP-PLA-EMR 
and NP-PLA-FHR was performed in duplicate. The experimental results were expressed 
as mean±standard deviation ( ±σ, n=3). 
 
Analysis by Scanning Electron Microscopy 
The surface morphology of the NP was observed through the scanning electron 
microscopy (SEM) (FEI Quanta 250 FEG) from the “Centre Technologique des 
Microstructures” (CT�) of the Claude Bernard University Lyon 1, France. For the 
preparation of the samples, one drop of each NP suspension was deposited in a metal 
sample holder and dried at room temperature. Finally, the samples were plated with 
platinum under vacuum. 
  
Anti-M. tuberculosis activity 
The anti-M. tuberculosis activity was evaluated on the susceptible strain of M. 
tuberculosis H37Rv by the alamar blue assay in a microplate adapting the methodology 
used by Molina-Salinas et al. (Molina-Salinas et al. 2007). The strain was cultivated in 
Middlebrock 7H9 broth enriched with OADC (Becton Dickinson and Co., Sparks, MD, 
USA) at 37 °C for 14 days. After, the strain was adjusted according to the standard scale 
no. 1 of McFarland and diluted 1:20 for use in the assay. On the other hand, a stock 
solution in DMSO was prepared at a concentration of 20 mg/mL. Work solutions were 
prepared from the stock solution. On the other hand, in a 96-well microplate, 200 ȝL of 
water was added to the wells in the periphery. While, in the work wells, 100 ȝL of 
Middlebrock 7H9 broth enriched with OADC was added. Subsequently, in the first well 
of each row, 100 ȝL of each previously prepared work solution was added. Once all the 
samples were added, serial dilutions 1:2 of each sample were performed, taking 100 ȝL 
of the first well and adding them to the second well of the row, then, of the second well, 
100 ȝL was taken to add them to the third, this procedure was repeated until reaching the 
last well each row; the 100 ȝL taken from the last well was eliminated. Finally, 100 ȝL of 
the bacterial suspension was added to obtain a final volume in all wells of 200 ȝL. The 
final concentrations for the EMH, FHR and RF1 were from 0.7 to 400 ȝg/mL; for RIF 
from 0.1 to 50 ȝg/mL; for NP-RIF from 12.5 to 400 ȝg/mL; for NP-EMR, NP-FHR and 
 16 
 
NP-RF1 from 5 to160 ȝg/mL. The microplates were incubated at 37 °C for 5 days. At day 
5, 20 ȝL of the blue alamar reagent and 1β ȝL of 10% v/v of tween 80 were added to all 
the work wells, and the microplates were reincubated at 37 °C for 24 h. The minimum 
inhibitory concentration (MIC) was determined from the color change of the blue to pink 
reagent. All tests were carried out at least in triplicate. 
In a second stage of the study, the RIF was combined with the EMR, FHR and 
RF1 in order to determine the mixture with the best activity. The work carried out by 
Avijgan (Avijgan et al., 2014). was taken as a reference. Then, RIF was combined with 
the formulation of NP-RF1 and NP-RIF formulation with NP-RF1 to determine if there 
was a synergism in the antimycobacterial activity. To carry out the evaluation, the 
concentration of RIF was varied by column and the concentration of the vegetable samples 
was varied by row. For example, for the RIF and RF1 combination, the RIF concentration 
was varied in the 1st row and the volume of the solution was kept constant with RF1 for 
a final concentration of 40 ȝg/mL; in the 2nd row the concentration of RIF was varied, 
and the volume of the solution was kept constant with RF1 for a final concentration of 20 
ȝg/mL and, thus, downwards. 
All analyzes were carried out in triplicate, except for the combination of RIF with 
EMR  (n=1). 
 
Hemolytic activity assay 
The assay of hemolytic activity was carried out according by UNE-EN ISO 10993-
4. A blood sample, from a healthy patient, was placed in a tube with 
ethylenediaminetetraacetic acid (EDTA), as an anticoagulant. The sample was 
centrifuged, discarding the plasma and the white cell pack, and preserving only the red 
blood cells (RBC) package. The RBC were washed three times with PBS (pH 7.4) in a 1:1 
ratio (RBC:PBS). After washing, the supernatant was discarded and the RBC were 
resuspended in PBS in a 1: 1 ratio (RBC:PBS) in order to obtain the working suspension 
of RBC. On the other hand, stock solutions of EMR and hexane fractions were dissolved 
in DMSO/PBS at a concentration of 1 mg/mL. Different concentrations of these samples 
were prepared from the stock solution, as well as NP formulations that showed the best 
activity against M. tuberculosis (NP-RIF and NP-RF1) in a range of 10 to 200 ȝg/mL in 
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DMSO from 0.1 to 2% v/v. The negative control to the hemolysis was prepared with 975 
ȝL of PBS and the positive control to the hemolysis was prepared with 975 ȝL of milli-Q 
water. 25 ȝL of the RBC suspension was added to all samples, including controls. The 
samples were incubated at 37 ° C for 1 h (VORTEMP 56, Labnet International, Inc., 
USA). After this time, the samples were centrifuged at 10,000 rpm for 10 min 
(Spectrafuge 24D, Labnet International, Inc., USA), recovering the supernatant of all the 
samples and adding them to a 96-well microplate. Finally, the absorbance of the 
supernatants was measure at Ȝ = 575 nm in a microplate reader (Epoch, BioTek 
Instruments, Inc., USA). The hemolytic activity was expressed as a percentage according 
to equation 7: 
 Hemolysis ሺ%ሻ = ஺஻�ೞ�೘೛೗೐ − ಲಳ�೙೐೒ ஺஻�೛೚ೞ  ܺ ͳͲͲ          (7) 
 
where, ABSsample is the absorbance of the supernatant from the sample, ABSneg is the 
absorbance of the negative control, and ABSpos is the absorbance of the positive control. 
All analyzes were carried out at least in triplicate. The experimental results were expressed 
as ±σ, n=3. 
 
RESULTS AND DISCUSION  
 
Yields of extracts of Leucophyllum frutescens and their fractions 
The methanol extracts from the leaves and roots of L. frutescens were obtained by 
ultrasound. As shown in Table I, the highest yield was obtained with the leaves. In the 
study published by Sultana et al. the same tendency is observed, there was a higher yield 
in leaves than in roots. They obtained the methanol extracts from leaves and roots of 
Moringa oleifera by two extraction techniques, with an orbital agitator at room 
temperature and under reflux in a water bath for 6 h, obtaining a yield with M. oleifera 
leaves of 9.6 and 16.6%, respectively. The yields in roots were of 3.2 and 5.1%, 
respectively (Sultana et al., 2009). Even, the yields for EMH is higher than EMR, 19.30 
and 7.92%, respectively. 
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The ultrasound used during the extraction of EMH and EMR can facilitate the 
swelling and solvation causing the enlargement of the pores of the cell wall. The greater 
swelling will improve the rate of mass transfer and, occasionally, it will break the cell 
walls, which leads to an increase in extraction efficiency and/or reduction in extraction 
time (Huie, 2002). Soares-Melecchi et. al. optimized the technique of extraction by 
ultrasound to obtain the extract from flowers of Hibiscus tiliaceus L They weighed 5 g of 
flowers and added 150 mL of methanol (1:30 ratio), reaching the highest yield (17.10%) 
in 5 h of extraction (Soares Melecchi et al., 2006). In our case, the ultrasound method 
developed to obtain the methanol extracts from leaves and roots of L. frutescens required 
less time (2 h). The percentages of yield of the fractions, with the methodology described 
above, are shown in Table I. When the hexane fraction is obtained, by any method, there 
was a higher yield in the hexane fractions from roots, it is possible to attribute greater 
number of related compounds in hexane by roots than leaves. While, increasing the 
polarity of the solvents, yields of leaves are observed higher than roots. 
 
Table I. Percentage of yield of methanol extracts from leaves and roots of Leucophyllum frutescens 
and its fractions 
Leaves EMH FHH HF1 HF2 HF3 HF4 HF5 
Yield (%) 19.30±4.20 3.46±0.09 2.55±0.31 6.10±4.34 1.17±0.28 33.05±3.09 3.48±0.12 
 
       
Roots EMR FHR RF1 RF2 RF3 RF4 RF5 
Yield (%) 7.92±0.38 9.62±5.04 10.46±0.99 7.19±0.36 0.40±0.05 13.99±4.06 16.27±0.56 
 
Chromatographic profiles of the extracts and fraction of Leucophyllum frutescens 
The extracts and fractions from leaves and roots were analyzed by CLAR to obtain 
their chromatographic profile. The variability within the plants of the same species 
depends on the collection station and the origin of the plant, among other factors (Nguyen 
Hoai et al., 2009). For this reason, the determination of the chromatographic profile is 
useful for the quality control of plant extracts (He et al., 2015; Kim et al., 2015; Xie et al., 
2007, Yang et al., 2013). 
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The extract and fractions obtained from leaves of the plant reveal the presence of 
4 main peaks (Figure 1), while the chromatographic profiles of the extract and fractions 
from roots reveal the presence of 7 main peaks (Figure 2). 
 
 
Figure 1.  Chromatographic profile of methanol extract from leaves of Leucophyllum frutescens 
(EMH) and its fractions (FHH, HF1, HF2, HF3, HF4 y HF5) at 400 µg/mL analyzed by HPLC. 
 
 
Figure 2. Chromatographic profile of methanol extract from roots of Leucophyllum frutescens (EMR) 
and its fraction (FHR, RF1, RF2, RF4 y RF5) at 400 µg/mL analyzed by HPLC. 
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Anti-M. tuberculosis activity of the extracts and fractions obtained from de 
Leucophyllum frutescens 
The activity of extracts and fractions of L. frutescens against M. tuberculosis 
H37Rv was evaluated by the alamar blue microplate method. MIC obtained from the assay 
are presented in Table II. EMH had a MIC value above 200 ȝg/mL while EMR had a MIC 
value of 100 ȝg/mL. In the study by Molina-Salinas et al. similar trends are reported, 
because in leaves the tested concentrations did not show activity, while in roots MIC was 
of 62.5 ȝg/mL (Molina-Salinas et al., 2007). Compared with our result, this variability in 
activity may be due to factors such as collection time or place of collection (Nguyen Hoai 
et al., 2009).  
 
Table II. Anti-M. tuberculosis activity H37Rv of the methanol extracts from leaves and roots of 
Leucophyllum frutescens and their fractions 
Leaves EMH FHH HF1 HF2 HF3 HF4 HF5 
MIC (µg/mL) >200 >200 >200 >200 >200 >200 >200 
 
       
Roots EMR FHR RF1 RF2 RF3 RF4 RF5 
MIC (µg/mL) 100 40 40 200 200 >200 >200 
 
The best activity against M. tuberculosis was collected with the hexane fractions 
from roots (FHR and RF1) at a MIC of 40 ȝg/mL. Comparing the methods of fractionation 
1 and 2, FHR and RF1, respectively, both demonstrate the same efficiency to the extract 
compounds related to hexane with antituberculosis activity. Previously, the isolation and 
identification of a compound extracted from roots with potent anti-M. tuberculosis activity 
was reported (Molina-Salinas et al., 2011), this fraction of interest was obtained with 
hexane, with a similar methodology to the fractionation method 1 performed in this work. 
However, an easy and rapid fractionation method was also developed (fractionation 
method 2), for the obtaining the fraction of interest preserving its antimycobacterial 
activity.  
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MIC achieved by FHR and RF1 is comparable to MIC reported in studies with 
other plants. Gemechu et al. investigated five medicinal plants in Ethiopia: roots of 
Calpurnia aurea, seeds of Ocimum basilicum, leaves of Artemisia abyssinica, Croton 
macrostachyus, and Eucalyptus camaldulensis used locally to fight tuberculosis. 
Methanol extracts of the plant materials were obtained by maceration and evaluated on M. 
tuberculosis strains such as: H37Rv, SIT73, SIT149, SIT149, SB1176 and SB1953, which 
were comparatively the most susceptible to the extracts with MIC of ≤50 ȝg/mL 
(Gemechu et al., 2013). However, Nguta et al. evaluated the antimycobacterial activity of 
the hydroethanol extract from leaves of Solanum torvum Aloe vera var. barbadensis, 
Dissotis rotundifolia, Chenopodium ambrosioides and rizosimas of Zingiber officinale 
Roscoe on M. tuberculosis H37Ra and H37Rv. It was determined that the leaves of S. 
torvum were the best potential anti-M. tuberculosis, since, they showed a MIC of 156.3 
and 1,250 ȝg/mL against M. tuberculosis H37Ra and H37Rv, respectively (Nguta et al., 
2016). Likewise, Kahaliw et al. obtained the chloroform extracts from roots of different 
plants, among them Pterolobium stellatum, which showed the highest MIC. The 
fractionation of this extract was carried out by solvent partition, in order to obtain the 
hexane and ethyl acetate fractions. In this case, the activity given by the fractions was 
greater than the extract (Kahaliw et al., 2017).  
According to the results published with other plants, root fractions are potential 
plant samples against M. tuberculosis. Following the mentioned chromatographic profile 
(Figure 2), in roots there are more peaks than in leaves. 
RF3 fraction was discarded for the determination of the chromatographic profile, 
antioxidant and haemolytic activity, due to experimentally a low percentage of yield and 
low anti-M. tuberculosis H37Rv were obtained. 
 
Chromatographic analysis of rifampicin  
Among the analytical methods, HPLC highlight, it allows the separation of the 
compounds according to their physiochemical characteristics, even if they are in a 
polymeric matrix (Moreno-Exebio y Grande-Ortiz, 2014).  
Initially, the chromatographic conditions that allowed the detection of RIF were 
developed. Figure 3 showed that the molecule was detected at a retention time of 2.0 min. 
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This result is close to the obtained retention time by Glass et al., who optimized a 
chromatographic method for the quantification of antituberculosis drugs. The retention 
time of RIF was 2.85 min using acetonitrile: tetrabutylammonium hydroxide (42.5:57.5, 
v / v) (0.2 mM) at a pH of 3.10 (Glass et al., 2007). 
 
 
 
Figure 3. Rifampicin chromatogram (30 ppm) obtained by HPLC (retention time=2 min). 
 
Preparation of the calibration curve and method validation for the quantification of 
rifampicin 
The validation was carried out to ensure that the analytical procedure is accurate 
for the quantification of RIF. Table 3 shows the validation parameters established for the 
developed method. The concentration range (5-30 ȝg/mL) had linearity, with a correlation 
coefficient greater than 0.99. LOD was 0.71 ȝg/mL, while LOQ was 2.14 ȝg/mL. On the 
other hand, repeatability and reproducibility were measured, obtaining a variation of 5.97 
and 6.79%, respectively. These values are acceptable, below the ±15% previously 
established (Glass et al., 2007), therefore the method is accurate. 
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Table III. Validation parameters of the chromatographic method for the quantification of rifampicin  
 
Preparation of the calibration curve of the methanol extract from leaves and roots 
of Leucophyllum frutescens 
As part of the characterization, from the chromatographic methods previously 
developed, the calibration curve of each plant sample (EMR, FHR and RF1) was analyzed 
in order to quantify the most abundant peaks in them, being selected the peak no. 5 in all 
the samples, and the peaks no. 6 and 7 in RF1. The method for RF1 quantification was 
validated by linearity, LOD and LOQ (Table IV).  
For extracts or fractions from plants, the known compounds of the plant are 
selected, and the chromatographic method is developed for their quantification. For 
example, in the Amorim et al. study, three flavonoids were identified in the hydroethanol 
extract from the aerial part of Tonina fluviatilis (6,7-dimethoxyquercetin- 3-O-ȕ-D-
glucopyranoside, 6-hydroxy-7-methoxyquercetin-3-O-ȕ-D-glucopyranoside and 6-
methoxyquercetin-3-O-ȕ-D-glucopyranoside) and a chromatographic method was 
developed and validated to quantify these compounds in the plant. For the preparation of 
the calibration curve, solutions of the three flavonoids were prepared and the regression 
equation for each was determined. LOD and LOQ of the calibration curves were below 
30 ȝg/mL (Amorim et al., 2014).  
For RF1 with the developed method, LOD and LOQ are superior because internal 
marker compounds of the fraction are used, it was possible preparing solutions of different 
concentrations of this hexane fraction for the preparation of the calibration curve, instead 
of standard solutions. The validation was carried out to ensure that the analytical 
procedure is accurate for the quantification of RF1 once it was loaded in NP (Martínez-
Rivas et al. 2017). 
 
 
Regression equation 
Correlation 
coefficient 
 (r) 
LOD 
(µg/mL) 
LOQ 
(µg/mL) 
Repeatability 
(RSD, %) 
Reproducibility 
(RSD, %) 
y = 8.8983x - 9.2698 0.99 0.71 2.14 5.97 6.79 
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Table IV. Validation parameters of the chromatographic method for the quantification of the 
vegetable samples from Leucophyllum frutescens 
(ND=no determinado) 
 
Encapsulation and characterization of rifampicin, methanol extract and hexanic 
fractions from roots of Leucophyllum frutescens loaded in polymeric nanoparticles 
Nanotechnology has emerged as a promising area to target the active to reservoirs 
such as macrophages (Nasiruddin et al., 2017). M. tuberculosis resides for a long period 
of time in the alveolar macrophages of the lungs (Jain et al., 2013).  
Due to the NP size, they are a promising vehicle for distribution through the body 
and to reach the target cells or organs. Nahar and Jain prepared NP with sizes of 150-200 
nm and negative zeta potential. Subsequently, they determined the targeting of 
Amphotericin B in PLGA NP conjugated with mannose and PEG to organs rich in 
macrophages (liver, kidney, spleen, lung and lymph nodes) in a bioavailability study. 
Swiss albino adult mice and males were injected with NP formulations, after the treatment 
they were sacrificed to analyze the organs. The results showed targeting of NP to organs 
rich in macrophages (Nahar y Jain, 2009). Comparing these results with our work, these 
characteristics of size and surface charge are favorable for their potential use. Table V 
describes the characterization parameters of RIF loaded NP. For the four formulations 
developed to encapsulate RIF, a particle size in a range of 140 – 180 nm was obtained, 
with homogeneous size distributions and negative zeta potential. 
The surface charge measured by the zeta potential is important because it is related 
to the stability of NP and drug release profiles (Honary y Zahir, 2013). The use of some 
Active 
No. 
Peak 
Regression equation 
Correlation 
coefficient  
(r) 
LOD 
(µg/mL) 
LOQ 
(µg/mL) 
EMR 5 y = 1.712x – 355.49  0.99 ND ND 
FHR 5 y = 1.4231x – 591.75 0.99 ND ND 
RF1 
5 y = 2.0497x – 105.57  0.99 209.22 634.00 
6 y = 0.3646x – 38.803  0.99 427.35 1295.00 
7 y = 1.3158 – 224.39  0.99 103.98 315.10 
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emulsifiers (surfactants) modifies the surface charge, although the emulsifiers used in this 
work are neutral (Mura et al. 2011), and their charge is modified depending on the pH of 
the medium. For example, PVAL has acetates groups that are negatively ionized as the 
medium change from pH 3 to pH 9 (Wiśniewska et al. 2016). Honary and Zahir prepared 
PLGA NP with two non-ionic surfactants, PVAL and Pluronic F68 (PF68). They obtained 
NP with negative zeta potential. The result obtained with PLGA-PVAL-NP was -5±1 mV 
and with PLGA-PF68-NP was -24±1 mV (Honary y Zahir, 2013), this formulation with 
PVAL presents a similar result compared with our work with this formulation (-5.57±1.35 
mV). 
 
Table V. Characterization parameters of the biodegradable polymeric nanoparticles containing 
rifampicin prepared by nanoprecipitation 
(Lut: Lutrol F127 NF: PVAL: polyvinyl alcohol); ND=not determined 
( ±σ, n=3) 
 
Then, the formulations were analyzed by CLAR for the quantification of the drug, 
this HPLC method was developed to detect RIF without interference from the polymeric 
matrix. As seen in Table V, the encapsulation percentages changed according to the 
polymer and surfactant involved in particle formation. NP formulation with the highest 
encapsulation of RIF was PLA-PVAL-NP formulation, with an encapsulation efficiency 
of 35.9%, which indicates that 35.9% of total RIF is encapsulated in NP. While, the lowest 
encapsulation was PLGA-PVAL-NP. This difference is given, because the polymer PLA 
has lower hydrophilic affinity than PLGA (Dalpiaz et al., 2016). Therefore, PLA is more 
related to hydrophobic drugs such as RIF. NP preparation technique used in this work 
Polymer 
Emulsifier 
agent 
Size 
(nm) PDI 
Zeta Potential 
(mV) %L  %EE 
PLA Lut 142.8±15.4 0.210±0.042 ND 2.8±0.1 30.4±0.3 
PLGA Lut 163.0±4.6 0.113±0.019 -15.93±3.10 0.7±0.1 6.0±1.0 
PLA PVAL 178.5±4.1 0.168±0.045 -7.89±1.82 2.2±0.1 35.9±1.0 
PLGA PVAL 176.3±9.4 0.139±0.007 -5.57±1.35 0.5±0.1 4.0±0.5 
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(nanoprecipitation) with the formulation parameters used, are favorable for formulating 
NP with RIF. 
Due to the results shown in the studies against M. tuberculosis, EMR and its 
fractions FHR and RF1 were selected to be encapsulated in NP. Table VI describes the 
characterization parameters of NP with plant samples. For the two formulations that were 
developed to encapsulate the EMR, FHR or RF1, a particle size in a range of 160 – 190 
nm was obtained, with homogeneous size distributions and negative zeta potential. 
As already mentioned, NP from 150 to 200 nm with negative zeta potential have 
shown targeting towards the organs rich in macrophages such as the lungs (Nahar y Jain, 
2009), NP with EMR, FHR or RF1 obtained in our work, are potential formulations to 
reach the lungs. Likewise, they have the characteristics for the internalization by the 
alveolar macrophages that contain the tuberculosis bacterium. Nicolete et al. observed that 
their blank PLGA NP with zeta potential of -17.2±6.1 mV were internalized by J774 
macrophages at 4 h. Therefore, they conclude that the size and surface chemistry of the 
particles influences their absorption (Nicolete et al., 2011). 
The peak no. 5 was selected to be quantified in NP, for being an abundant 
component in plant samples. The peak was encapsulated in all formulations, which 
indicates that the NP preparation method is favorable for the encapsulation of extracts or 
fractions extracted from L. frutescens plant. Some researchers have encapsulated plant 
compounds in NP such is the case of do Nascimento et al., who encapsulated the red 
propolis extract in five formulations of poly-ɛ-caprolactone (PCL) NP and quantified five 
flavonoids (liquiritigenin, pinobanksin, isoliquiritigenin, formononetin and biochanin A) 
by UPLC. %EE of the flavonoids in NP had an average value of 75% (do Nascimento et 
al., 2016). However, in this work the chromatographic method was designed to detect the 
components of interest of the extracts and fractions obtained from L. frutescens and using 
them as internal markers for their quantification in NP. 
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Table VI. Characterization parameters of the biodegradable polymeric nanoparticles containing 
methanol extract and hexane fractions from Leucophyllum prepared by nanoprecipitation 
( ±σ, n=3 and n=2) 
 
Finally, the surface morphology of the NP by MEB was determined. Figure 4 
shows the micrographs obtained from the blank NP, RIF NP and RF1 NP. NP had a 
spherical shape and a smooth surface, with a size around 80 nm and homogeneous 
distribution in all formulations. 
 
Active  Polymer 
Size 
(nm) 
PDI 
Zeta Potential 
(mV) 
No. 
Peak 
%EE 
EMR 
PLA 160.7±2.7 0.259±0.045 -9.79±036 
  
5 78.10±11.67 
  
PLGA 176.0±7.0 0.150±0.018 -6.11±1.16 
  
5 57.94±5.08 
  
FHR 
PLA 189.8±2.2 0.114±0.019 -11.23±1.86 
  
5 21.65±1.60 
  
PLGA 171.5±10.6 0.127±0.025 -7.76±1.64 
  
5 21.63±1.01 
  
RF1 
PLA 180.5±2.1 0.110±0.013 -10.77±2.69 
5 83.82±3.61 
6 81.42±16.53 
7 83.42±8.16 
PLGA 170.3±4.4 0.094±0.012 -7.73±1.49 
5 77.71±1.0 
6 55.47±10.86 
7 63.72±7.84 
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Figure 4. MEB image of PLGA nanoparticles prepared by nanoprecipitation. A and D blank 
nanoparticles; B and E: nanoparticles with rifampicin; C and F: nanoparticles with the hexane 
fraction of Leucophyllum frutescens roots (A, B, and C: scale bar represents 1 μm; D, E and F: scale 
bar represents 500 nm). 
 
Anti-Mycobacterium tuberculosis activity of the nanoparticle formulations  
Once the formulations of NP were obtained, they were evaluated against M. tuberculosis. 
In Table VII, MIC of the formulations of NP with RIF are shown, the complete 
formulations (encapsulated and non-encapsulated active) and the formulations with the 
encapsulated active were evaluated. Likewise,  MIC for RIF was determined (0.20 
ȝg/mL). PLGA NP showed the best encapsulation, and it is the PLGA-PVAL formulation 
with encapsulated active that had the highest activity (0.10 ȝg/mL) even compared with 
the free drug. This enhancement in the antibacterial activity of the drug encapsulated in 
PLGA NP compared with its free form has already been observed in other studies. 
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As example is the work carried out by Darvishi et al., who incorporated 18-ȕ-
glycyrrhetinic acid (GLA) in PLGA NP with a size around 200 nm and negative zeta 
potential to test them against: Pseudomonas aeruginosa, Staphylococcus aureus and 
Staphylococcus epidermidis. MIC of NP with GLA and free GLA for P. aeruginosa was 
around 75 and 20 ȝg/mL, respectively; for S. aureus was of 75 and 35 ȝg/mL, respectively; 
and, for S. epidermidis was of 35 and 10 ȝg/mL, respectively. The results revealed that 
GLA NP had better activity than free GLA (Darvishi et al., 2015).  
 
Table VII. Minimal inhibitory concentration (MIC) of biodegradable polymeric nanoparticles 
containing rifampicin (n=3) 
 
     
MIC 
Formulations 
Encapsulated non-encapsulated 
rifampicin (µg/mL) 
Encapsulated rifampicin 
(µg/mL) 
RIF-PLGA-Lut 0.20 0.30 
RIF-PLA-PVAL 0.40 0.90 
RIF-PLGA-PVAL 0.20 0.10 
 
As mentioned, the best antimycobacterial activities were given by EMR, FHR and 
RF1 (MIC=100, 40 and 40 ȝg/mL, respectively), so they were selected to be formulated 
in NP. Table VIII shows the results of the assay for the determination of the activity of 
the NP formulations containing EMH, FHR or RF1, being FHR-PLGA-NP and RF1-
PLGA-NP with the best activities. These results suggest that PLGA-PVAL-NP enhanced 
the activity against M. tuberculosis compared to free forms of RIF, FHR and RF1. 
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Table VIII. Minimal inhibitory concentration (MIC) of biodegradable polymeric nanoparticles 
containing the vegetable actives (n=3) 
Formulations 
MIC encapsulated and non-encapsulated 
active (µg/mL) 
EMR-PLA 400 
EMR-PLGA 400 
FHR-PLA 160 
FHR-PLGA 80 
RF1-PLA 160 
RF1-PLGA 80 
 
Subsequently, the combined effect between RIF and EMR, FHR or RF1 was 
evaluated, the best combination was achieved with RIF and RF1, MIC decreased from 
0.20 to 0.10 ȝg/mL and 40 to 10 ȝg/mL, respectively (Table VIII). From this favorable 
combination, the combined effect of RIF with RF1-PLGA-NP and RIF-PLGA-NP with 
RF1-PLGA-NP was tested. The combination RIF-PLGA-NP with RF1-PLGA-NP did not 
have a better effect than the free combination. However, the combination of RIF with 
RF1-PLGA-NP, showed a better MIC for both, from 0.20 to 0.10 ȝg/mL and 80 to 20 
ȝg/mL, respectively. It means, when RF1 is in NP, it is possible to enhance the effect of 
its free form. These results suggested that the combination of RIF with a hexane fraction 
from roots of L. frutescens against M. tuberculosis is favorable. The combination of drugs 
with natural agents increases the spectrum of activity and decreases the risk of emergence 
of resistant strains (Avijan et al., 2014). 
 
 
 
 
 
 
 31 
 
Table IX. Minimal inhibitory concentration (MIC) of rifampicin with methanol extract and hexane 
fractions from L. frutescens roots against M. tuberculosis 
 
Hemolysis assay 
One of the techniques for measuring compatibility can be through the 
determination of hemolysis (Fischer et al., 2003). The test of the extracts and their 
fractions was carried out according by UNE-EN ISO 10993-4 which establish that a 
percentage lower than 5% is considered non-hemolytic, considering the value of 100% to 
the total amount of hemoglobin present in the RBC sample added. RF5 showed no 
hemolysis at the concentrations analyzed. In contrast, RF2 and RF4 maintain a non-
hemolytic effect at ≤100 ȝg/mL, and EMR at ≤β5 ȝg/mL, Finally, the hexane fractions 
FHR and RF1 are non-hemolytic at ≤10 ȝg/mL (Figure 5).  
Comparing the results of hemolytic activity with the M. tuberculosis activity, in 
EMR, FHR and RF1 there was presence of hemolysis at the established MIC (100, 40 and 
40 ȝg/mL, respectively). Vega Menchaca et al. Vega Menchaca et al. evaluated the acute 
toxicity of the methanol extract from L. frutescens leaves. They carried out the evaluations 
in Artemia salina, reporting a LD50 of 196.37 ȝg/mL, , and in the VERO cell line, reporting 
an IC50 of 58.0 ȝg/mL (Menchaca et al., 2013). These results suggest the presence of 
toxicity in the plant. 
 
 
MIC of rifampicin 
(µg/mL) 
 
MIC of vegetable samples 
 (µg/mL) 
EMR 0.10  + 100 
FHR 0.10 + 20 
RF1 0.10  + 10 
RF1-PLGA-NP 0.10  + 20 
 32 
 
 
Figure 5. Hemolytic activity of the vegetables samples from Leucophyllum frutescens: methanol 
extract and fractions ( ±σ, n=3). 
 
Also, the hemolysis percentage was determined as an indicator of the toxicity of 
RIF and NP formulations. For the concentration of RIF with activity against M. 
tuberculosis MIC were determined: i) free form (0.20 ȝg/mL), ii) in combination (0.10 
ȝg/mL) and iii) RIF-PLGA-PVAL, being the formulation with the best activity. The 
results showed there was no presence of hemolysis. While, RF1 and RF1-PLGA-NP at 
the MIC against M. tuberculosis (40 and 80 ȝg/mL, respectively) are hemolytic. However, 
when RF1 is combined with RIF, the concentrations decreased from 40 to 10 ȝg/mL for 
RF1 and from 80 to 20 ȝg/mL for the NP formulation, and at these concentrations there 
was no presence of hemolysis (Figure 6). Additionally, Figure 6 showed that the 
encapsulation of RF1 in NP favors the reduction of its toxicity. 
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Figure 6. Hemolytic activity of the encapsulated hexane fraction from roots of Leucophyllum 
frutescens (RF1 NP) and non-encapsulated (RF1) ( ±σ, n=3). 
 
Table X. Percentage of hemolysis of rifampicin, hexane fraction from roots of Leucophyllum 
frutescens and nanoparticles 
 
(E+NE=complete batch; E=encapsulated active) 
          ( ±σ, n=γ)  
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RF1
RF1 NP
ANTITUBERCULOSIS 
ACTIVE  
CONCENTRATION 
(µg/mL) 
HEMOLYTIC ACTIVITY 
(%) 
RIF 0.20 N/H 
RIF 0.10 N/H 
RIF-PLGA-NP (E+NE) 0.20 N/H 
RIF-PLGA-NP (E) 0.10 N/H 
RF1 40 94.35±4.37 
RF1 10 N/H 
RF1-PLGA-NP (E+NE) 80 8.62±2.65 
RF1-PLGA-NP (E+NE) 20 N/H 
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CONCLUSION 
In this study several evaluations were carried out in order to have a broader 
knowledge about the biological activity of L. frutescens. The ultrasound method 
developed to obtain the methanol extract of leaves and roots of the plant allowed to 
achieve a good performance in a short time (2 h). Two different fractionation methods 
were developed in order to obtain the hexane fraction of leaves and roots, the percentage 
of yield obtained with both methods was very close. However, method 2 was selected to 
continue with the following partitions because it is faster and easier to execute. 
The chromatographic profiles of the extracts and fractions were obtained by 
HPLC, these results revealed that there was the same number of peaks of the extract 
(leaves or roots) and the fractions obtained from it; as well as, particularly in roots, the 
greatest number of peaks was found. 
The evaluation of the activity against M. tuberculosis of the extracts and the 
fractions revealed that the roots are more active, specifically, EMR, FHR and RF1 with 
MIC of 100, 40 and 40 ȝg/mL, respectively. However, hemolysis occurred at these 
concentrations. 
On the other hand, biodegradable NP of RIF and plant samples (EMR, FHR and 
RF1) of L. frutescens were prepared by nanoprecipitation. The characterization of the 
formulations showed NP from140 to 190 nm, with homogeneous distributions and 
negative zeta potential. When RIF is encapsulated in PLGA-PVAL-NP enhanced its 
activity against M. tuberculosis (0.10 ȝg/mL) compared to the PLA-PVAL-NP and the 
free drug. The extract and fractions had a higher MIC when they are encapsulated. The 
most active formulations were with the fractions, showing better activity with PLGA NP 
(80 ȝg/mL) compared to PLA NP (160 ȝg/mL). 
The combination of plant samples with RIF decreased the MIC in both cases, 
demonstrating a better effect. At the active concentrations against M. tuberculosis, RIF 
and RIF loaded NP did not present hemolysis. Whereas, RF1 and RF1 loaded NP showed 
hemolysis at the active concentrations against M. tuberculosis. However, when RF1 is 
combined with RIF, the concentrations decreased from 40 to 10 ȝg/mL for RF1 and from 
80 to 20 ȝg/mL for the NP formulation, and at these concentrations there is no presence 
of hemolysis. 
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This suggests that the encapsulation of RF1 in NP favors the reduction of its 
toxicity. Therefore, an alternative to make use of these fractions, with potential activity 
against the bacteria causing tuberculosis and without hemolytic effect is to combine it with 
conventional antituberculosis drugs. 
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CHAPTER 2. POTENTIAL USE OF Leucophyllum frutescens AS 
ANTIOXIDANT AGENT AND ITS ENCAPSULATION IN 
POLYMERIC NANOPARTICLES 
 
ABSTACT 
 
Leucophyllum frutescens has been studied mainly for its activity against Mycobacterium 
tuberculosis but other biological properties in the plant have been less studied. In addition, 
for advance in the investigation of the plant to the application in some organism, it would 
be promising to transport the natural components in polymeric nanoparticles (NP), thus 
avoiding the use of organic solvents. It should be noted that NP have different advantages 
that improve the biological activity of the contained active. The objective of this work was 
to encapsulate an extract or fraction, with antioxidant activity, obtained from the methanol 
extract of L. frutescens. With nanoencapsulation, the vegetable sample is incorporated in 
a vehicle free of organic solvents, without losing its property, making possible to 
administer it in the body. First, the antioxidant activity of the extracts and fractions from 
leaves and roots of L. frutescens were evaluated to select the ethanolic fraction from leaves 
(HF4) as the most active. The chromatographic profile of the ethanol fraction of leaves 
was determined by High Performance Liquid Chromatography (HPLC), selecting four 
peaks-components for their use as internal markers in order to quantify them once the 
plant sample was encapsulated in NP. For quantification of the component peaks in NP, 
firstly, the chromatographic method was partially validated. The regression equations of 
the four peaks were obtained, with correlation coefficients greater than 0.99. In addition, 
the limit of detection and limit of quantification of each peak was determined resulting in 
43.09 and 130.58, 38.62 and 117.03, 22.29 and 67.53 and, 45.86 and 138.97 ȝg/mL, for 
peaks 1, 2, 3 and 4, respectively. Suspensions of HF4 loaded NP were obtained by the 
nanoprecipitation method. NP had particle sizes around 200 nm with homogeneous 
distributions. While, the percentage of encapsulation of peaks 1, 2, 3 and 4 was 20, 23, 61 
and 80%, respectively. Then, the antioxidant activity was evaluated using the oxidant 
peroxyl, 2,2-azo-bis-(2-amidinopropane) dihydrochloride (AAPH) in red blood cells. The 
fraction HF4 presented antioxidant activity at 100 ȝg/mL and when HF4 was encapsulated 
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in NP, the activity was preserved. Finally, through the hemolysis test was concluded that 
HF4 and HF4-NP are not toxic to the active concentrations. Therefore, the potential use 
of HF4 loaded NP as an antioxidant agent is promising. 
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INTRODUCTION 
Several compounds with biological activity from plants, have been isolated and 
identified. One of the most common examples is Taxol®, which was obtained from the 
plant called Taxus breuifolia (Wani et al., 1971). The large number of plants existing in 
the earth leads to the acquisition of new compounds or the promising discovery of 
activities not yet known in species not yet studied.  
Leucophyllum frutescens, de la familia Scrophulariaceae, of the family 
Scrophulariaceae, is a plant commonly known as "cenizo". In Nuevo León it is the bush 
par excellence. In Texas it is called "shrub barometer" because its flowering depends on 
humidity in the environment and rainfall (Zaragoza, 2009). L. has been studied mainly for 
its activity against Mycobacterium tuberculosis (Alanís-Garza et al., 2012; Molina-
Salinas et al., 2007, 2011). Some studies suggest other biological properties present in the 
metabolites of the plant. 
However, a property not yet studied is its antioxidant capacity. Throughout the 
antioxidant effect, the body is protected from oxidative stress caused by free radicals. Free 
radicals play a fundamental role in different diseases such as cancer, inflammatory 
diseases or neurological disorders caused by age (Lobo et al., 2010).  
There are several studies focused on the investigation of the antioxidant activity of 
plants. Generally, the antioxidant properties are attributed to a chemical group called 
polyphenols (Özkan y Özcan, 2017). In the study by Saeed et al., some extracts were 
obtained from the plant Torilis leptophylla, were studied, where the presence of phenols 
were found, which were related to their antioxidant activity. Likewise, an in vivo study 
suggested that methanol extract could be used against oxidative damage caused by carbon 
tetrachloride (CCl4) by its antioxidant property (Saeed et al., 2012). 
To produce free radicals using the peroxyl initiator, 2,2-azo-bis-(2-
amidinopropane) dihydrochloride (AAPH) in red blood cells (RBC) causes hemolysis, 
however, adding an antioxidant prevents hemolysis. Therefore, this system is an adequate 
model to determine the antioxidant activities of extracts or fractions of plants (An et al., 
2014). This method allowed to Jiang et al. to investigate the protection conferred by the 
aqueous extract of Pueraria thomsonii and Pueraria lobata on the RBC damage of rats 
caused by free radicals. No antioxidant activity was shown by the aqueous extract of P. 
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thomsonii, with an IC50 around 1000 ȝg/mL. In contrast, the extract of P. lobata exhibited 
a potent activity, with an IC50 of 194.0±6.9 µg/mL (Jiang et al., 2005).  
A limitation in the use of plant extracts with potential as antioxidant agents is on 
their in vitro or in vivo application because they are obtained in an organic solvent, which 
cannot be administered to an organism. A proposal to transport natural components is the 
use of polymeric nanoparticles (NP), because they show different advantages that improve 
the biological activity of the sample (Christofoli et al., 2015). 
For this reason, the aim of this work was to encapsulate an ethanol fraction 
obtained from the methanol extract of L. frutescens leaves, with antioxidant activity in 
order to contain it in a vehicle free of organic solvents without loss of activity, and thus to 
obtain a formulation with potential administration in an organism. 
 
MATERIALS AND METHODS 
 
Obtaining of the extracts of Leucophyllum frutescens and their fractions  
Chapter 1 describes the procedure for obtaining the extracts from leaves and roots 
of L. frutescens and its fractions. Briefly, L. frutescens plant was collected in Monterrey, 
N. L., Mexico in July 2013. Consequently, the plant material was washed, dried at room 
temperature and pulverized. 50 g of powdered leaves or roots were weighed, 350 mL of 
methanol was added. The extracts were obtained by ultrasound (Ultrasonic Cleaners, 
VWR Symphony, USA). For a period of 1 h, the temperature for the extraction was 
increased from 25 to 60 ºC, once reached 60 ºC, three cycles of 10 min of sonication and 
10 min of rest were performed. Subsequently, the samples were filtered to obtain the 
solvent, which was evaporated under reduced pressure (Laborota 4003 control, Heidolph) 
in order to obtain the methanol extract of leaves (EMH) and roots (EMR). With respect to 
the fractionation of the extracts, two methods were used. In the method 1, EMH was 
solubilized in methanol, it was placed in a separatory funnel and hexane was added; 
subsequently, both solvents were mixed, and the hexane part was recovered and 
evaporated under reduced pressure in order to obtain the hexane fraction (FHH). The same 
procedure was followed with the EMR in order to obtain the hexane fraction from roots 
(FHR). 
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In the method 2, hexane was added to the EMH and stirred to aid the solubilization 
of the compounds related to the solvent, then, it was filtered to obtain the solvent and 
evaporated obtaining the hexane fraction called HF1. Chloroform was added to the solid 
insoluble in hexane, stirred, filtered to obtain the solvent with the compounds related to 
chloroform and evaporated obtaining the chloroformic fraction (HF2). This procedure was 
repeated with other solvents of higher polarity (ethyl acetate, ethanol and methanol) in 
order to obtain the HF3-HF5 fractions. The fractionation method 2 was also performed to 
the EMR, identifying the obtained fractions as RF1-RF5. 
 
Determination of the antioxidant activity of the extracts and fractions from 
Leucophyllum frutescens  
The antioxidant activity was measured by the damage of RBC producing free 
radicals with AAPH, the methodology described by Abajo et al. (2004). was used as 
reference. A blood sample, from a healthy patient, was placed in a tube with 
ethylenediaminetetraacetic acid (EDTA), as an anticoagulant. The sample was 
centrifuged, discarding the plasma and the white cell pack, preserving only the RBC 
package. RBC were washed three times with a solution of phosphates with salt (PBS, pH 
7.4) in a ratio of 1:1 (RBC: PBS). After the washing, the supernatant was discarded, and 
the RBC were resuspended in PBS to subsequently dilute them 1:10 (RBC:PBS) in order 
to obtain the working suspension of RBC. 
  On the other hand, stock solutions of EMH, EMR and fractions in DMSO were 
prepared. Also, one solution of AAPH at 400 mM in PBS was prepared. Then, a volume 
of each sample was taken to obtain the final concentrations in a range of 10 to 200 ȝg/mL 
in DMSO (0.15 to 3% v/v). The antioxidant control was ascorbic acid (AA), which was 
prepared at the same concentrations as the plant samples. 375 ȝL of the AAPH solution 
and 250 ȝL of the RBC suspension were added to all the samples. 
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The oxidant control was PBS, 375 ȝL of the AAPH solution and 250 ȝL of the RBC 
suspension. Two controls were added, one negative to the hemolysis (750 ȝL of PBS and 
250 ȝL of RBC) and another positive to hemolysis (750 ȝL of milli-Q water and 250 ȝL 
of RBC). All test samples had a final volume of 1000 ȝL. Samples and controls were 
incubated at 37 ° C for 2.5 h with constant agitation (300 rpm) (VORTEMP 56, Labnet 
International, Inc., USA). After this time, the samples were centrifuged at 10,000 rpm for 
10 min (Spectrafuge 24D, Labnet International, Inc., USA), recovering the supernatant of 
all the samples and adding them to a 96-well microplate. Finally, the absorbance of the 
supernatants at Ȝ=575nm was measured in a microplate reader (Epoch, BioTek 
Instruments, Inc., USA). The oxidative damage was determined by equation 1: 
 Oxidative damage ሺ%ሻ = ஺஻�ೞ�೘೛೗೐ − ಲಳ�೚� ஺஻�೛೚ೞ  ܺ ͳͲͲ                       ሺͳሻ           
 
where, ABSsample is the absorbance of the supernatant of the sample, ABSox is the 
absorbance of the supernatant of the oxidant control and ABSpos is the absorbance of the 
supernatant of the positive control to the hemolysis. From this result the antioxidant 
activity was determined: 
 Antioxidant activity ሺ%ሻ = ͳͲͲ − ݋��݀����݁ ݀�݉�݃݁ ሺ%ሻ      ሺʹሻ    
 
All analyzes were carried out at least in triplicate. The experimental results were expressed 
as mean±standard deviation ( ±σ, n=3). 
 
Determination of the hemolytic activity of the extracts and fractions from 
Leucophyllum frutescens  
The assay of hemolytic activity was carried out according by UNE-EN ISO 10993-
4. A blood sample, from a healthy patient, was placed in a tube with 
ethylenediaminetetraacetic acid (EDTA), as an anticoagulant. The sample was 
centrifuged, discarding the plasma and the white cell pack, and preserving only the red 
blood cells (RBC) package. The RBC were washed three times with PBS (pH 7.4) in a 1:1 
ratio (RBC:PBS). After washing, the supernatant was discarded and the RBC were 
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resuspended in PBS in a 1: 1 ratio (RBC:PBS) in order to obtain the working suspension 
of RBC. 
On the other hand, stock solutions of EMR and hexane fractions were dissolved in 
DMSO/PBS at a concentration of 1 mg/mL. Different concentrations of these samples 
were prepared from the stock solution, as well as NP formulations that showed the best 
activity against M. tuberculosis (NP-RIF and NP-RF1) in a range of 10 to 200 ȝg/mL in 
DMSO from 0.1 to 2% v/v. The negative control to the hemolysis was prepared with 975 
ȝL of PBS and the positive control to the hemolysis was prepared with 975 ȝL of milli-Q 
water. 25 ȝL of the RBC suspension was added to all samples, including controls. The 
samples were incubated at 37 ° C for 1 h (VORTEMP 56, Labnet International, Inc., 
USA). After this time, the samples were centrifuged at 10,000 rpm for 10 min 
(Spectrafuge 24D, Labnet International, Inc., USA), recovering the supernatant of all the 
samples and adding them to a 96-well microplate. Finally, the absorbance of the 
supernatants was measure at Ȝ = 575 nm in a microplate reader (Epoch, BioTek 
Instruments, Inc., USA). The hemolytic activity was expressed as a percentage according 
to equation 3: 
 Hemolysis ሺ%ሻ = ஺஻�ೞ�೘೛೗೐ − ಲಳ�೙೐೒ ஺஻�೛೚ೞ  ܺ ͳͲͲ          (3) 
 
where, ABSsample is the absorbance of the supernatant from the sample, ABSneg is the 
absorbance of the negative control, and ABSpos is the absorbance of the positive control. 
All analyzes were carried out at least in triplicate. The experimental results were expressed 
as ±σ, n=3. 
 
Chromatographic analysis  
For the obtaining of the chromatographic profile of HF4, it was dissolved in 
acetonitrile (J. T. Baker, USA)/methanol (Tedia, USA), the solution was filtered through 
a 0.45 ȝm filter (Millipore, USA) to be analyzed by HPLC (VARIAN 9065, 9012, ProStar 
410, USA). A Synergi™ 4 ȝm Fusion-RP 80 Å (150 mm x 2.0 mm x 4 ȝm) column, a 
flow of 0.2 mL/min and 30 °C was used. The mobile phase was formic acid (purity: 90%, 
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Millipore, USA) at 0.1% v/v and methanol with an isocratic elution of 45:55 for 40 min 
for leaves and 60 min for roots. The profiles were detected at Ȝ=224 nm. 
 
Preparation of the calibration curve and method validation  
HF4 was weighted and disolved in methanol (Tedia, USA), to obtain a stock 
solution at 2000 µg/mL. From the stock, the working solutions were prepared in the range 
from 100 to 700 µg/mL and filtered through a 0.45 ȝm membrane (Millipore, USA), they 
were analyzed by the HPLC method before mentioned to obtain the calibration curve.  
The chromatographic method was validated through the variables: linearity, limit 
of detection (LOD) and limit of quantification (LOQ) according to the International 
Conference on Harmonization (ICH). For the establishment of the linearity, the calibration 
curve was prepared and analyzed in triplicate. The LOD and LOQ were calculated by the 
following equations: 
 Limit of detection ሺLODሻ = ͵.͵ �ܵ                 ሺͶሻ 
 Limit of quantification ሺLOQሻ = ͳͲ �ܵ         ሺͷሻ 
 
where, � is the standard deviation of the response and S is the slope of the calibration 
curve.    
 
Encapsulation of the ethanol fraction from leaves of Leucophyllum frutescens in 
polymeric nanoparticles and its characterization   
 Once the validation parameters were established, NP containing HF4 were 
prepared by the nanoprecipitation technique proposed by Fessi et al. (Fessi et al., 1989). 
Briefly, the organic phase was prepared dissolved 15 mg of polylactic-co-glycolic acid 
(PLGA; MEDISORB 85 15 DL) and 4 mg of HF4 in 3 mL of a mixture of solvents 
(acetone:methanol). The organic phase was added to 10 mL of an aqueous phase, 
containing polyvinyl alcohol (PVAL) (Clariant, Mexico) as a stabilizer agent at a 
concentration of 1% w/w. Then, the organic solvent was evaporated under reduced 
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pressure. The NP characterization was carried out determining the particle size and 
polydispersity index (PDI) by dynamic light scattering (Zetasizer Nano ZS90, Malvern 
Instruments, UK). To determine the drug loading and encapsulation efficiency (%L and 
%EE), the NP formulations were centrifuged at 25,000 rpm (Allegra 64R, Beckman 
Coulter, USA), the supernatant was decanted, and the pellets were lyophilized (Freeze 
Dry System, LABCONCO, USA). The lyophilized NP were dissolved in acetonitrile and 
methanol. The obtained solutions were analyzed by HPLC to quantify the peaks 
encapsulated from the calibration curve of each one, the results obtained were substituted 
in the following equations: 
 Drug loading ሺ%Lሻ = ܹ݁�݃ℎ� ݋݂ �ℎ݁ �ܿ���݁ �݊ ��ܹ݁�݃ℎ� ݋݂ �ℎ݁ �� ݌݈݈݁݁�   ܺͳͲͲ  ሺ͸ሻ 
 Encapsulation efficiency ሺ%EEሻ = ܹ݁�݃ℎ� ݋݂ �ℎ݁ �ܿ���݁ �݊ ��ܹ�݃ℎ� ݋݂ ܴ��   ܺͳͲͲ  ሺ͹ሻ 
 
All the analyzes were carried out in triplicate. The experimental results were 
expressed as ±σ, n=3. 
 
Determination of the antioxidant activity of the ethanol fraction from Leucophyllum 
frutescens leaves in polymeric nanoparticles 
To evaluate the antioxidant activity of HF4 loaded NP, a suspension of RBC was 
prepared as previously described. For the preparation of the samples, solutions of AA and 
HF4 were prepared, the volume of the NP dispersion containing HF4 was taken to obtain 
the final concentrations of 25 to 200 ȝg/mL. 375 ȝL of the AAPH solution and 250 ȝL of 
the RBC suspension were added to all the samples. The antioxidant control was ascorbic 
acid (AA), which was prepared at the same concentrations of the plant samples. 375 ȝL 
of the AAPH solution and 250 ȝL of the RBC suspension were added to all the samples. 
The oxidant control was PBS, 375 ȝL of the AAPH solution and 250 ȝL of the 
RBC suspension. Two controls were added, one negative to the hemolysis (750 ȝL of PBS 
and 250 ȝL of RBC) and another positive to hemolysis (750 ȝL of milli-Q water and 250 
ȝL of RBC). All test samples had a final volume of 1000 ȝL. Samples and controls were 
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incubated at 37 ° C for 2.5 h with constant agitation. After this time, the samples were 
centrifuged at 10,000 rpm for 10 min, recovering the supernatant of all the samples and 
adding them to a 96-well microplate. Finally, the absorbance of the supernatants at 
Ȝ=575nm was measured in a microplate reader. The results of the assay was determined 
by equation 1 and 2. 
All analyzes were carried out at least in triplicate. The experimental results were 
expressed as ±σ, n=3. 
 
Determination of the hemolytic activity of the etanol fraction from Leucophyllum 
frutescens leaves in polymeric nanoparticles  
To evaluate the hemolytic activity of the HF4 in NP, a suspension of RBC was 
prepared as previously described. For the preparation of the samples, the necessary 
volume of the dispersion of NP containing HF4. The samples were tested in a 
concentration range from β5 to β00 ȝg/mL. The negative control to the hemolysis was 
prepared with 975 ȝL of PBS and the positive control to the hemolysis was prepared with 
975 ȝL of milli-Q water. 25 ȝL of the RBC suspension was added to all samples, including 
controls. The samples were incubated at 37 ° C for 1 h. After this time, the samples were 
centrifuged at 10,000 rpm for 10 min, recovering the supernatant of all the samples and 
adding them to a 96-well microplate. Finally, the absorbance of the supernatants was 
measure at Ȝ=575 nm in the microplate reader. The hemolytic activity was expressed as a 
percentage according to equation 3. The experimental results were expressed as ±σ, n=3. 
 
RESULTS AND DISCUSION  
 
Determination of the antioxidant activity of the extracts and fractions of 
Leucophyllum frutescens  
Adding AAPH to RBC, free radicals are generated by oxidative damage in the 
lipids of the cell membrane, consequently, the hemolysis of the cell is induced. The 
hemolysis can be avoided with the presence of antioxidant substances. The extracts and 
fractions that exhibit antioxidant activity can protect the cell against oxidative damage, as 
a result, the RBC lysis is avoided. Paiva-Martins et al., for example, made use of this 
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method to determine the inhibition of the oxidative lysis of RBC. They obtained the 
compound called and 3,4-dihydroxyphenylethanol-elenolic acid dialdehyde (3,4-
DHPEA-EDA) of olive oil and synthesized its metabolite 3,4-DHPEA-EDAH2. Its 
objective was to induce the oxidative stress of RBC by AAPH, and to add the compounds 
obtained to measure the capacity of them to protect the cells. Both compounds showed 
RBC protection from oxidative hemolysis at concentrations ranging from 10 to 80 ȝM. 4-
DHPEA-EDA achieved 70% of protection at 80 ȝM (Paiva-Martins et al., 2015).   
In the present study with L. frutescens, the samples with the best activity were 
obtained from leaves. The EMH, and the fractions HF1, HF2, HF3 and HF4 reached a 
protection around 80% from 50 ȝg/mL. While, the HF5 fraction reached this percentage 
from 100 ȝg/mL (Figure 1). 
 
 
Figure 1. Percentage of the antioxidant activity of the methanol extract from leaves of L. frutescens 
and its fractions ( ±σ, n=3). 
 
The ascorbic acid (AA) control presents antioxidant activity from 50 ȝg/mL 
(Figure 2). The results with L. frutescens revealed a protective effect at concentrations 
close to plants commonly reported with antioxidant activity. Karimi et al. investigated the 
aqueous and ethanol extracts of seeds of Nigella sativa L. and the aerial part of Portulaca 
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oleracea L. in order to evaluate the cytoprotective effect of the extracts against the 
hemolytic damage induced by the free radical initiator AAPH. In general, the 
concentrations tested were from 25 to 1800 ȝg/mL, being from 150 ȝg/mL where an 
antioxidant effect is observed in the extracts (Karimi et al., 2011). In contrast, FHH 
reached its highest protection capacity (around 70%) at 50 ȝg/mL, at higher concentrations 
this property decreases. This percentage decreases because at the same time, it has a 
hemolytic effect. Despite being obtained with the same solvent (hexane), the results for 
FHH and HF1 are different, therefore the fractionation method influenced the antioxidant 
activity of each fraction.  
On the other hand, EMR reached 80% of protection from 25 to 50 ȝg/mL, however, 
when the tested concentration was 100 ȝg/mL, its antioxidant activity decreases (Figure 
2). 
 
 
Figure 2. Percentage of the antioxidant activity of the methanol extract from roots of L. frutescens 
and its fractions ( ±σ, n=3).  
 
As evidenced in Figure 2, the same behavior of EMR can be seen in its fractions. 
In the hexane fractions FHR and RF1, protection above the 80% is maintained in the range 
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of 10 to 12.5 ȝg/mL, for RF2 and RF4 from 25-50 ȝg/mL and 50-150 ȝg/mL, respectively. 
In contrast, the antioxidant activity in RF5 is maintained from 50 to 200 ȝg/mL. Probably, 
the protection of the EMR, FHR, RF1, RF2 and RF4 samples decreased as presented in 
Chapter 1, they have a hemolytic effect, while in RF5 there is no presence of hemolysis. 
All these results demonstrated that, the EMH, HF1, HF2, HF3, HF4, HF5 and RF5, could 
be used in a range from 25 to 200 ȝg/mL and obtain an antioxidant effect, even, this effect 
can be comparable to AA control. Meanwhile, FHH, EMR, FHR, RF1, RF2 and RF4 could 
be used at specific concentrations. 
 
Determination of the hemolytic activity of the methanol extract from leaves of 
Leucophyllum frutescens and its fractions  
Because, extracts and fractions obtained from L. frutescens leaves showed greater 
antioxidant activity, we proceeded to the determination of toxicity by hemolysis. 
The test of the extracts and their fractions was carried out according to UNE-EN 
ISO 10993-4, which states that a percentage lower than 5% is considered non-hemolytic. 
TEMH, HF1, HF2, HF3, HF4 and HF5 did not show hemolysis at the analyzed 
concentrations (25-200 ȝg / mL), while the FHH was not hemolytic below 25 ȝg/mL. 
 
Chromatographic analysis  
Of all the plant samples with antioxidant activity evaluated in the present work, 
HF4 fraction was selected to be encapsulated in NP. Firstly, it was analyzed by a HPLC 
to observe its chromatographic fingerprint or its peak profile, which is a useful tool for 
quality control, as well as to determine the amount of peaks or components present in the 
vegetable sample (Bian et al., 2013).  
The chromatographic method developed allowed the separation of four peaks or 
components of interest in HF4 (Figure 3). This method was validated in order to use it for 
the quantification of peaks 1-4, once the fraction in the NP was encapsulated. 
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Figure 3. Chromatographic profile of the ethanol fraction from Leucophyllum frutescens leaves (700 
μg/mL) obtained HPLC, showing four peaks-components of interest (retention times: 15.10, 18.20, 
22.60 and 27.80 min, respectively). 
 
Calibration curve of HF4 and validation of the chromatographic method  
The regression equation of each peak-component (1-4) was obtained from the 
calibration curve shown in Figure 4. As shown in Table 1, the correlation coefficients for 
the calibration curve of each peak-component were greater than 0.99. LOD and LOQ for 
each peak 1, 2, 3 and 4 were 43.09 and 130.58, 38.62 and 117.03, 22.29 and 67.53 and, 
45.86 and 138.97 ȝg/mL, respectively. 
In the area of natural products, when it is required to quantify a peak from a known 
molecule present in an extract, it is compared with the standard analyzed by the same 
chromatographic method. Such is the case of Assunção et al. who developed and validated 
a method by CLAR for the quantification of ellagic acid in the ethanol extracts from leaves 
of Eugenia uniflora L. (Myrtaceae) (Assunção et al., 2017). In our work a 
chromatographic method was developed and validated by CLAR using peaks-components 
as internal markers for the quantification of HF4 in NP. 
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Figure 4. Calibration curve of the four peaks-components of interest present in the ethanol fraction 
from Leucophyllum frutescens roots ( ±σ, n=3). 
 
Table I. Validation parameters of the four peaks-components of interest present in the ethanol 
fraction from Leucophyllum frutescens roots by HPLC  
 
Encapsulation and characterization of the ethanol fraction from Leucophyllum 
frutescens leaves in polymeric nanoparticles  
Once the method was validated, HF4 was encapsulated in NP by the 
nanoprecipitation method. The characterization of the formulation of NP with HF4 is 
shown in Table 2. NP sizes were obtained around 200 nm with a homogeneous size 
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Peak-Component Regression equation  
Correlation 
coefficient  
 (r) 
LOD 
(µg/mL) 
LOQ 
(µg/mL) 
1 y = 1.4826x + 1.8489 0.99 43.83 130.58 
2 y = 0.4121x + 2.5638 0.99 38.62 117.03 
3 y = 1.9841x – 14.17  0.99 22.29 67.53 
4 y = 0.4178x – 13.207  0.99 45.86 138.97 
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distribution (0.118). The lyophilized NP pellet with HF4 was dissolved in a mixture of 
acetonitrile: methanol, and the obtained solution was analyzed by HPLC. The area under 
the curve of each peak was replaced in its regression equation (Table 1), in order to obtain 
the concentration of the four component peaks in NP. Consequently, equations 6 and 7 
were used to determine %L and %EE of peaks 1, 2, 3 and 4 in NP, being 4.13 and 19.83, 
4.89 and 23.48, 12.81 and 61.52 and, 16.56 and 79.53%, respectively. 
The encapsulation of the peaks increased as the hydrophobic nature of the peaks 
increased, the highest hydrophobicity was observed with peak 4 and therefore the highest 
encapsulation. Sanna et al., obtained white tea extract by infusing the leaves in distilled 
water, after, it was encapsulated in poly-ɛ-caprolactone NP (PCL) and alginate as particle-
forming polymers using the nanoprecipitation technique. The optimal formulation had a 
size around 380 nm and a unimodal distribution. They determined the %EE of two 
catechins, (-)-epigallocatechin gallate and (-)epicatechin gallate, with values of 30.62 and 
32.60%, respectively (Sanna et al., 2015). In our work, higher %EE were determined, 
probably due to the nature of the components present in the L. frutescens fraction. 
 
Table II. Polymeric nanoparticles characterization containing the ethanol fraction from 
Leucophyllum frutescens leaves 
 Quantification 
Size (nm) PDI Peak-Component %L %EE 
206.4±3.3 0.118±0.026 
1 4.13±0.76 19.83±3.76 
2 4.89±0.86 23.48±4.25 
3 12.81±2.19 61.52±11.17 
4 16.56±3.21 79.53±16.21 
( ±σ, n=γ) 
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Determination of the antioxidant and hemolytic activity of the etanol fraction from 
Leucophyllum frutescens leaves 
The method used to determine the antioxidant activity of the HF4 NP was by the 
induction of oxidative damage of RBC with the reagent AAPH which generates 
hemolysis. Hemolysis of the RBC damage can be avoided with the presence of antioxidant 
substances. Figure 5 shows the antioxidant activity of HF4, HF4 NP and AA. HF4 fraction 
revealed around 80% of protection against oxidative damage (antioxidant activity) at 50 
ȝg/mL. Achieving 100% antioxidant activity above 100 ȝg/mL. If this concentration is 
compared with the AA molecule evaluated as an antioxidant control, HF4 had better 
activity. When HF4 is encapsulated in NP, at 50 ȝg/mL the activity is around 80%; while 
100% of antioxidant activity is reached at 100 ȝg/mL. In free HF4, total antioxidant 
activity is revealed at 100 ȝg/mL. Therefore, it is demonstrated that, although this fraction 
is formulated in NP, the antioxidant property is preserved. 
 
 
Figure 5. Antioxidant activity of the ethanol fraction from leaves of Leucophyllum frutescens (HF4) in 
its non-encapsulated and encapsulated form in biodegradable polymeric nanoparticles (NP). Ascorbic 
acid (AA) was taken as an antioxidant control ( ±σ, n=3).  
 
In the aforementioned research by Sanna et al., the antioxidant activity of the white 
tea extracts was evaluated by the in vitro 2,2-diphenyl-1-picrylhydrazyl (DPPH) method. 
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The best activity of PCL NP was of DPPH, observed at 300 ȝg/mL with 60% of inhibition 
compared to the free extract that shoed 100% of inhibition of DPPH at 25 ȝg/mL. 
They attributed this difference to the low release of polyphenols from PCL NP 
(Sanna et al., 2015). Less activity is obtained at a higher concentration if it is compared 
with our result, this may be due to the nature of the polymers, because PCL has a slower 
degradation rate compared with polylactics (Mahapatro y Singh, 2011), which is related 
to his low release. Likewise, the toxicity was evaluated by the hemolytic activity at active 
concentrations, determining that there is no presence of hemolysis. This test results in the 
potential use of HF4 fraction formulated or not formulated in NP for administration in the 
organism, however, it is in NP where the use of the organic solvents is avoided. 
 
CONCLUSION 
The extracts and fractions of L. frutescens plant showed protection, avoiding the 
lysis of RBC caused by the oxidation induced with the AAPH reagent. However, FHH, 
EMR, FHR, RF1, RF2 and RF4, presented their maximum antioxidant activity at low 
concentrations and, subsequently, decreased when they were tested at higher 
concentrations. While, EMH, HF1, HF2, HF3, HF4, HF5 and RF5 were plant samples 
with antioxidant activity from 25 to 200 ȝg/mL and non-hemolytic effect. HF4 fraction 
was selected for the studies that proceeded. This fraction was of interest for the antioxidant 
activity that it presented at a concentration of 100 ȝg/mL, showing better activity than the 
reference antioxidant molecule AA. 
A method was developed to obtain the chromatographic profile of HF4 by HPLC. 
The chromatographic method was validated to be used for the quantification of four peaks-
components in NP presented in the fraction. The encapsulation of the four peaks in NP 
was determined, it revealed a favorable incorporation of the L. frutescens fraction. 
Suspensions of NP loaded with HF4 were obtained by the nanoprecipitation 
method, which had a particle size around 200 nm with a homogeneous distribution. 
Likewise, when HF4 was incorporated in NP the activity is conserved. Because the 
encapsulation of the fraction is achieved, the incorporation of HF4 in NP is of potential 
use as an antioxidant agent, its properties are preserved, and it is non-toxic at the active 
concentrations. 
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CHAPTER 3. RIFAMPICIN AND AN ACTIVE FRACTION OF Leucophyllum 
frutescens LOADED NANOEMULSIONS, CHARACTERIZATION AND 
POTENTIAL USE AGAINST Mycobacterium tuberculosis 
 
ABSTRACT 
The interest on the use of nanoemulsions (NE) is related to its application as drug delivery 
systems. NE have shown several advantages such as the incorporation of hydrophobic 
drugs into a hydrophilic dispersion medium, the targeting to an organ or cell, the cellular 
uptake and the increased bioavailability. In recent years, special interest has been placed 
on the encapsulation of natural products such as extracts and essential oils obtained from 
plants to improve their biological effects. Among the plants that have been investigated is 
included Leucophyllum frutescens commonly named “cenizo”, it has been demonstrated 
effect against the microorganism Mycobacterium tuberculosis, causal agent of 
tuberculosis. For this reason, the aim of this work was to optimize and characterize a NE 
to encapsulate an active fraction from roots of L. frutescens (RF1), as well as, the 
antituberculosis drug rifampicin (RIF), and to evaluate their activity in vitro against M. 
tuberculosis. NE were prepared by ultrasonic emulsification and the influence of different 
preparation variables was tested. The results showed that at a longer time of sonication, 
the size and the polydispersity index (PDI) of NE globules decreased. The increase in the 
surfactant concentration, decreased the size and increased slightly the PDI. The increase 
in the amount of oil phase, increased the size and decreased slightly the PDI. The 
formulation of NE with a particle size around 180 nm and with homogeneous size 
distribution, was used for the encapsulation of the actives (RF1 and RIF). In a previous 
study, RF1 was determined as an active fraction against M. tuberculosis. The 
characterization of the loaded NE showed a particle size of 180 nm. For the determination 
of the percentage of the encapsulation efficiency of RF1, most abundant peaks were 
selected, being encapsulated at least 70%, while RIF was encapsulated at 99%. For the 
anti-M. tuberculosis activity were tested the blank NE, RF1-NE and RIF-NE, where, the 
blank NE showed inhibition at the same concentration as RF1-NE and RIF-NE, this 
behavior can be attributed to the presence of oleic acid as the oil phase. With this work 
the encapsulation and characterization of a vegetal sample (RF1) and RIF in NE are 
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achieved. The optimal NEs characterized and tested are promising in the inhibition of M. 
tuberculosis. 
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INTRODUCTION 
NE are systems thermodynamically unstable and kinetically stable are on nanometric 
scale (Gupta et al., 2016). The interest for NE is related to the prospects of applications 
such disperse systems in medicine, in pharmaceutical and cosmetic industries (Koroleva 
y Yurtov, 2012). A nanoemulsion is constituted by oil, water and emulsifier (Gupta et al., 
2016). The emulsifier or emulsifying agent is a surfactant that reduces the interfacial tension 
between the immiscible phases, provide a barrier around the droplets and prevent coalescence of 
the droplets (Manoharan et al., 2010).  
The methods for the emulsion preparation are classified in high- and low-energy. 
The high-energy methods include mechanical shear such as that produced by high-shear 
stirring, ultrasonic emulsification, high-pressure homogenization. The low-energy method 
most widely used is phase inversion temperature (Koroleva y Yurtov, 2012). 
 They can be administrated by oral (Devalapally et al., 2013), intranasal (Kumar et 
al., 2008), topical (Hussain et al., 2016) and parenteral routes (Araújo et al., 2011). They can 
be formulated in variety of formulations such as foams, creams, liquids, sprays (Jaiswal et al., 
2015) or gels (Hussain et al., 2016). As drug delivery systems studies have demonstrated 
many advantages such as incorporation of hydrophobic drug into a hydrophilic medium, 
targeting, cellular uptake and bioavailability. 
A study carried out by Kumar et al., has demonstrated it with an antipsychotic 
drug. A risperidone nanoemulsion (RNE) was prepared using capmul MCM as the oily 
phase and tween 80 as surfactant. A mixture of transcutol and propylene glycol was used 
as co-surfactant and distilled water as the aqueous phase. A risperidone mucoadhesive 
nanoemulsion (RMNE) was prepared by addition of chitosan. The globule size range was 
15.5–16.7 nm. They proved the biodistribution of RNE, RMNE and risperidone solution 
(RS) in the brain and blood of Swiss albino rats by intranasal (i.n.) and intravenous (i.v.) 
administration. The brain/blood ratios of 0.617, 0.754, 0.948, and 0.054 of RS (i.n), RME 
(i.n), RMME (i.n) and RME (i.v), respectively, at 0.5 h are indicative of direct nose to 
brain transport bypassing the blood–brain barrier. Also, they obtained scintigraphy images 
following intravenous administration of RNE and intranasal administration of RNE and 
RMNE. The scintigrams demonstrate the accumulation of formulations in brain 
administered via respective routes. Major radioactivity accumulation was seen in brain 
 57 
 
following intranasal administration of RMNE as compared to intravenous administration 
of RNE. For mucoadhesive nanoemulsions indicated more effective and best brain 
targeting of RSP. Added, significant quantity of risperidone was quickly and effectively 
delivered to the brain by intranasal administration of formulated. This study conducted in 
rats clearly demonstrated effectiveness of intranasal delivery of risperidone as an 
antipsychotic agent (Kumar et al., 2008).  
Another study by Hussain et al. reveal controlled and extended release profile and 
non-irritant properties of NE contained a broad-spectrum fungicidal antibiotic used 
primarily in the treatment of life-threatening systemic fungal infections. They prepared a 
NE and NE gel for topical delivery of amphotericin B (AmB) using sefsol-218 oil, Tween 
80 and Transcutol-P. Then, NE was incorporate into the carbopol gel (1% w/w) 
formulation. The in vitro drug release for AmB NE was 42.12% and AmB NE gel was 
10.96%. Formulation had shown 2.0- and 9.12-fold slower drug release, respectively, as 
compared to AmB solution (99.97%) in first 2 h suggesting controlled. The in vitro skin 
permeation study revealed NEs increase permeation rate. The cumulative amount of drug 
permeated at the end of 24 h was found to be 254.161± 1.45 mg, 870.42±4.2 mg and 
999.81±7.3 mg for AmB DS, NE (pH 7.4) and AmB-NE gel, respectively. Also, the 
irritation potential of topical formulations was evaluated on Wistar albino rats. In this 
study, the results showed that no severe irritation symptoms such as erythema (redness) 
and edema (swelling) during 72 h except reference positive (Hussain et al., 2016).  
In recent years, special interest has been placed in the encapsulation of natural 
products as extracts and essential oils obtained from plants to enhance their biological 
effects (Blanco-Padilla et al., 2014). Donsì et al. proved the activity of different essential 
oil components: carvacrol, limonene and cinnamaldehyde in the sunflower oil droplets of 
nanoemulsions. The antimicrobial activity was measured against three different 
microorganisms, such as Saccharomyces cerevisiae (ATCC 16664), Escherichia coli 
(ATCC 26) and Lactobacillus delbrueckii sp. Lactis (ATCC 4797). The microorganisms, 
centrifuged at 6500 rpm for 5 min at 4 ◦C, were resuspended in sterile distilled water to a 
final concentration of 104 CFU/mL in test tubes, where the nanoemulsions were added to 
the desired final antimicrobial concentrations. The testtubes were hence incubated at 32 
◦C for S. cerevisiae and L. delbrueckii and at γ0 ◦C for E. coli. After 2 h and 24 h, the 
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surviving cells were evaluated by standard plate count method. The antimicrobial activity 
of formulations was evident over a longer time scale (24 h) (Donsì et al., 2012). Tsai y 
Chen extracted catechins from tea leaf waste of Camellia sinensis (L.) Kuntze. The 
catechin extract was incorporated in NE and tested in human prostate cancer cell PC-3 
and human fibroblast cell CCD-986SK. After 72 h incubation catechin nanoemulsion 
exhibited a lower toxicity toward CCD-986SK cells than catechin extract. While, catechin 
nanoemulsion had a major inhibitory effect in prostate cancer cell PC-3 proliferation with 
the IC50 being 8.5 µg/mL than catechin extract with IC50 being 15.4 µg/mL (Tsai y Chen, 
2016).  
Some studies have focused on the use of plants against the microorganism M. 
tuberculosis, causal agent of tuberculosis, with the aim of reducing the large number of 
new cases and mortalities that occur per year. The plant known as "cenizo" L. frutescens 
has been studied for this purpose. Molina-Salinas et al. determined that the methanol 
extracts from leaves and roots showed activity against M. tuberculosis (Molina-Salinas et 
al., 2007). However, few compounds obtained from L. frutescens have been identified 
(Alanís-Garza et al., 2012; Molina-Salinas et al., 2011).   
In this context, the aim of the study was to optimize and characterize of a NE to 
encapsulate an active fraction obtained from the methanol extract of roots of L. frutescens, 
as well as, the antituberculosis drug RIF, and the in vitro evaluation against M. 
tuberculosis. 
 
MATERIALS AND METHODS 
 
Preparation of Leucophyllum frutescens hexane fraction 
Roots of L. frutescens were collected in Monterrey, N. L., Mexico in July 2013. 
Consequently, the plant material was washed, dried at room temperature and pulverized. 
50 g of powdered leaves or roots were weighed, 350 mL of methanol was added. The 
extracts were obtained by ultrasound (Ultrasonic Cleaners, VWR Symphony, USA). For 
a period of 1 h, the temperature for the extraction was increased from 25 to 60 ºC, once 
reached 60 ºC, three cycles of 10 min of sonication and 10 min of rest were performed. 
Subsequently, the samples were filtered to obtain the solvent, which was evaporated under 
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reduced pressure (Laborota 4003 control, Heidolph) in order to obtain the methanol 
extract of roots (EMR). Hexane was added to the EMR, stirred to aid the solubilization of 
the compounds related to the solvent, filtered to obtain the solvent and evaporated 
obtaining the hexane fraction called RF1. 
 
Preparation, optimization and characterization of nanoemulsions 
Briefly, oleic acid (OA) as oil phase was emulsified in a tween 80 solution as 
aqueous phase with ultrasonic emulsification (Homogeneizador, OPTIC IVYMEN 
SYSTEM) with 80% amplitude. The influence of different variables in the preparation of 
emulsions were proved. Firstly, different times of sonication (3, 5, 6, 7 and 8 min) were 
tested with 4g of oleic acid and 96g of a tween 80 solution at 2%w/v. Then, the 
concentration of tween 80 was changed (1, 1.5, 2, 3 and 4% w/v). Finally, different 
amounts in oil/aqueous phase were proved (1.5/98.5, 2/98, 3/97, 3.5/96.5 and 4/96 g). All 
the formulations were prepared in triplicated. The hydrodynamic diameter, polydispersity 
index (PDI) and zeta potential of each emulsion were measured by dynamic light 
scattering (Zetasizer Nano ZS90, MALVERN). Zeta potential was determined at 5 
different pH (3, 5, 7, 9 and 11). Their stabilities were followed by hydrodynamic diameter, 
PDI and the separation of oil/aqueous phases over time.  
 
Preparation and characterization of hexane fraction of Leucophyllum frutescens and 
rifampicin loaded emulsions  
Different formulations of RF1 and RIF were prepared by ultrasonic emulsification. 
Briefly, the organic phase containing RF1 or RIF in oleic acid was emulsified in the 
aqueous phase containing a solution of T-80 (1% w/v). Then, NE were characterized by 
the measurement of hydrodynamic diameter, polydispersity index (PDI), zeta potential 
and stability. The actives in NE were quantified by high performance liquid 
chromatography (HPLC) (WATERS). 
RF1 quantification was carried out indirectly, centrifuging the samples (Eppendorf 
5415 centrifuge) at 5000 rpm for 30 min, to separate the aqueous phase from the globules. 
The aqueous phase was taken and analyzed on a Phenomenex C18 column with a flow of 
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0.2 mL/min at 30 °C. The mobile phase was water (A) and methanol (B) in a isocratic 
elution 45:55 (A: B) for 60 min. The detection of the RIF peak was at Ȝ=210 nm. 
 RIF quantification was carried out indirectly, centrifuging the samples (Eppendorf 
5415 centrifuge) at 5000 rpm for 30 min, to separate the aqueous phase from the globules. 
The aqueous phase was taken and analyzed on a Phenomenex C18 column with a flow of 
0.35 mL/min at 30 °C. The mobile phase was water (A) and acetonitrile (B) in a isocratic 
elution 40:60 (A: B) for 15 min. The detection of the RIF peak was at Ȝ=334 nm.  
 
Anti-Mycobacterium tuberculosis activity of the active fraction of Leucophyllum 
frutescens and rifampicin loaded in the nanoemulsions   
The anti-M. tuberculosis activity was evaluated on the susceptible strain of M. 
tuberculosis H37Rv by the alamar blue assay in a microplate adapting the methodology 
used by Molina-Salinas et al. (Molina-Salinas et al., 2007). The strain was cultivated in 
Middlebrock 7H9 broth enriched with OADC (Becton Dickinson and Co., Sparks, MD, 
USA) at 37 °C for 14 days. After, the strain was adjusted according to the standard scale 
no. 1 of McFarland and diluted 1:20 for use in the assay. On the other hand, in a 96-well 
microplate, 200 ȝL of water was added to the wells in the periphery. While, in the work 
wells, 100 ȝL of Middlebrock 7H9 broth enriched with OADC was added. In the first well 
of each row, 100 ȝL of each sample (NE blank, NE-RF1 and NE-RIF) and control samples 
(RF1, RIF and tween 80 solution) were added. Once all the samples were added, serial 
dilutions 1:2 of each sample were performed, taking 100 ȝL of the first well and adding 
them to the second well of the row, then, of the second well, 100 ȝL was taken to add 
them to the third, this procedure was repeated until reaching the last well each row; the 
100 ȝL taken from the last well was eliminated. Finally, 100 ȝL of the bacterial suspension 
was added to obtain a final volume in all wells of 200 ȝL. All samples were prepared in 
duplicate in the same day. The microplates were incubated at 37 °C for 5 days. At day 5, 
20 ȝL of the blue alamar reagent and 12 ȝL of 10% v/v of tween 80 were added to all the 
work wells, and the microplates were reincubated at 37 °C for 24 h. The minimum 
inhibitory concentration (MIC) was determined from the color change of the blue to pink 
reagent. All tests were carried out at least in triplicate. 
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RESULTS AND DISCUSION  
 
Preparation, optimization and characterization of nanoemulsions 
The emulsions were prepared with oleic acid as oil phase and tween 80 as 
surfactant. Oleic acid was chosen due to M. tuberculosis has shown the ability to utilize 
this fatty acid complexed with triton as a source of carbon for growth was determined 
(Hedgecock, 1970), and with a nanocarrier based in oleic acid will be possible M. 
tuberculosis takes it more effectively than others.  
As part of the optimization, different preparation variables of NE were evaluated. 
Firstly, the influence of the sonication time (3, 5, 6, 7 and 8 min) on the particle size and 
PDI was determined (Figure 1). When time was increased the hydrodynamic diameter and 
PDI decreased from 215.7±3.2 nm to 155.6±0.2 nm and from 0.319±0.025 to 
0.244±0.009, respectively. The ultrasonic emulsification is very efficient in reducing 
droplet size. Here, the energy is provided through a sonicator probe. It contains 
piezoelectric quartz crystal which can expand and contract in response to alternating 
electric voltage. As the tip of sonicator contacts the liquid, it produces mechanical 
vibration and cavitation occurs. Cavitation is the formation and collapse of vapour cavities 
in liquid. Thus, ultrasound can be directly used to produce emulsion (Jaiswal et al., 2015). 
It means, more exposure time to emulsification more energy that allows smaller droplet 
size. The stability tests showed in the range of 5 to 8 min, a size change around 30 nm 
from day 0 to day 77 (data not shown), being from 7 min where a homogeneous size 
distribution was maintained during this period. 
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Figure 1. Effect of the sonication time on the hydrodynamic diameter ( ±σ, n=3). 
 
To continue with the influence of T-80 concentration was used a time sonication 
of 7 min and 4g of OA. The increased of tween 80 concentration from 1 to 4% w/v 
decreased the droplet size from 195.1±1.4 nm to 156.1±4.1 nm but the PDI increased 
slightly from 0.201±0.006 to 0.285±0.005 (Figure 2). The same behaviors on the droplet 
sizes were observed in the study carried out by Ghosh et al. They prepared NE by 
ultrasonic emulsification with an oil phase containing cinnamon oil and Tween 80 as 
surfactant. Three different cinnamon oil and Tween 80 as surfactant ratios (1:1, 1:2 and 
1:3 v/v) were proved at 10, 20 and 30 min of ultrasonic emulsification and steady decrease 
in droplet size of emulsion was observed from ~400 to 250 nm, ~250 to 96 nm and ~200 
to 65 nm, respectively. T-80 concentration also played a major role in droplet size of 
nanoemulsion. Increasing surfactant concentration resulted in decrease in droplet 
diameter. Formulation with 6% surfactant concentration after sonication for 30 min was 
found to be 254 nm, whereas formulation with 12% surfactant was 96 nm and formulation 
with 18% surfactant has lowest droplet diameter of 65 nm after a sonication period of 30 
min (Ghosh et al., 2013).  
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Figure 2. Effect of the concentration of Tween 80 solution on the hydrodynamic diameter ( ±σ, n=3). 
 
Finally, the influence of the oil and aqueous phase amount on hydrodynamic 
diameter was evaluated, maintaining a sonication time of 7 min and tween 80 solution at 
1% w/v. When the oil amount increased while aqueous phase decreased the droplet size 
at the same time from 126.3±0.7nm to 195.1±1.4 nm (Figure 3) and the PDI decreased 
slightly from 0.259±0.003 to 0.201±0.006. 0.259 ± 0.003 to 0.201 ± 0.006. Mantena et al. 
found this influence on size who prepared NE by aqueous phase titration method. Capryol 
90 as oil, Tween 20 as surfactant and Transcutol P as cosurfactant. They maintained a 
constant percentage of surfactant (30%) and co-surfactant (10%) in the formulation and 
the percentage of oil was 10, 15 and 20% at the same time the percentage of water changed 
in 50, 45 and 40%. The size increased from 234.9 nm to 285.8 nm (Mantena et al., 2015). 
The size of the NE droplets supposes an increase, when increasing the oil ratio, the amount 
of phase is reduced, as a consequence the chains of the surfactant are reduced, increasing 
the interfacial tension (Du et al., 2016).  
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Figure 3. Effect of the ratio on the amount of oleic acid (oil phase) and 1% w/v of Tween 80 solution 
(aqueous phase) on the hydrodynamic diameter ( ±σ, n=3).  
 
The NE prepared for the evaluation of the influence of the preparation variables were 
stable up to 77 days, likewise, all the formulations showed a negative zeta potential. The 
negative value can be explained by the presence of negatively charged carboxyl groups of 
oleic acid (Laouini et al., 2012). The negative value can be explained by the presence of 
negatively charged carboxyl groups of oleic acid (DeRuiter, 2005). The pKa of oleic acid 
is 5.02 (Pubchem). This explain when we compared at pH 3 the zeta potential is closer 0 
(around -3 mV) with pH 5 to pH 11 (-40 to -70 mV) a greatly increased in the negativity 
can be observed. 
 
Preparation and characterization of the hexanic fraction of Leucophyllum frutescens 
and rifampicin loaded in nanoemulsions  
Subsequently, an optimal NE was selected for the preparation of two formulations, 
for the encapsulation of RF1 and RF1. For the preparation of RF1-NE and RIF-NE the 
sonication time of 7 min, the concentration of T80 at 1% w/v and the ratio in the amount 
of oleic acid and aqueous phase of 3.5/96.5 were selected. g. The obtained particle size 
with these variables was around 180 nm (Table I) and a homogeneous size distribution 
(Figure 4). 
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Table I. Characterization of nanoemulsions containing rifampicin and the hexane fraction from 
Leucophyllum frutescens roots 
Active 
Hydrodynamic 
diameter (nm) 
PDI Encapsulation efficiency (%) 
RIF 179.3±3.5 0.213±0.014 99.9±0.0 
RF1 179.1±1.4 0.217±0.002 
Peak 5 75.8±3.5 
Peak 9 86.5±4.7 
Peak 10 72.8±0.4 
Peak 14 70.6±17.4 
Peak 15 84.7±5.3 
( ±σ, n=γ) 
 
 
Figure 4. Size distribution of nanoemulsions by intensity percentage: (A) rifampicin loaded 
nanoemulsion; (B) hexane fraction from roots of Leucophyllum frutescens.   
 
Lately, the encapsulation of both active in NE was determined by CLAR. In Figure 
5 the chromatogram with the RIF peak in an aqueous solution is observed. When the 
sample obtained from the centrifugation of the NE was analyzed, it was determined that 
the molecule is 99% encapsulated. Ahmed et al. prepared a NE with RIF using Sefsol 218 
as oil and T80 as emulsifier and tween 85 as a co-emulsifier. They found an encapsulation 
efficiency of around 100% with stability for more than 19 months (Ahmed et al., 2008).  
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On the other hand, RF1 was dissolved in methanol in order to observe its 
chromatographic profile, it showed 15 peaks (Figure 6). The peaks 5, 9, 10, 14 and 15 
were selected for their quantification within the NE, obtaining an encapsulation efficiency 
greater than 70%. Similar results were obtained by Ha et al. when determined the 
encapsulation of lycopene in a tomato extract formulated in NE, which was 51 to 65% 
(Ha et al., 2015).  For both formulations, a negative zeta potential (Figure 7) and stability 
(without phase separation) were observed over 77 days (Figure 8). 
 
 
Figure 5. Chromatogram of rifampicin in water (9 μg/mL) obtained by CLAR: (A) water peak; (B) 
rifampicin peak, retention time = 3.2 min. 
 
 
Figure 6. Chromatogram of the hexane fraction from roots of Leucophyllum frutescens (230 μg/mL) 
obtained by CLAR: (A) peaks of methanol. 
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Figure 7. Effect of the pH of the dispersion medium of the nanoemulsions on the zeta potential: blank 
nanoemulsions (NE), containing rifampicin (RIF-NE) and containing the hexane fraction from roots 
of Leucophyllum frutescens (RF1-NE) ( ±σ, n=3).   
 
 
Figure 8. Stability of blank nanoemulsions (NE), containing rifampicin (RIF-NE) and containing the 
hexane fraction from roots of Leucophyllum frutescens (RF1-NE) ( ±σ, n=3).  
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Anti-Mycobacterium tuberculosis activity of the active fraction of Leucophyllum 
frutescens and rifampicin loaded nanoemulsions 
Finally, the activity against M. tuberculosis of the three NE (blank NE, RIF-NE 
and RF1-NE) was evaluated by alamar blue microplate method. The test is based on the 
color change from blue to pink of the reagent. MIC of RIF and RF1 without encapsulation 
was 0.19 and 40 ȝg/mL, respectively. Blank NE showed inhibition when oleic acid and 
T80 were at 68.10 and 18.75 ȝg / mL, respectively. While the RIF-NE and RF1-NE 
showed inhibition when the actives were at a concentration of 0.19 and 0.39 ȝg/mL, 
respectively, but OA and T80 were at a concentration of 68.10 and 18.75 ȝg/mL, 
respectively, as in blank NE. Choi proved an unsaturated acid called linoleic acid (α and 
Ȗ form) against M. tuberculosis, in both cases fatty acid forms obtained a MIC of 75 ȝg/mL 
(Choi, 2016). Therefore, in our study, the inhibition of blank NE can be explained by the 
presence of oleic acid. It was not possible to observe the effect of the activity of RIF and 
RF1 when they were in NE due to the presence of the fatty acid. 
 
CONCLUSION 
The effect of sonication time, surfactant concentration and oil/aqueous phase ratio 
on particle size, PDI, zeta potential and stability for NE optimization was tested. The 
optimal formulation was used for the encapsulation of RF1 and RIF having a diameter 
around 180 nm, homogenous size distribution, negatively charged and, they were stable 
for 77 days. Both formulations showed high efficiency of encapsulation. The anti-M. 
tuberculosis activity showed inhibition in the same concentrations including blank NE, 
this behavior can be attributed due to the presence of oleic acid as oil phase. The optimal 
NE characterized and tested are promising for their use against M. tuberculosis. 
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VIII. CONCLUSIONS 
In this study some investigations with the extracts and fractions from L. frutescens 
were carried out in order to obtain a broader knowledge about the biological activity 
present in the plant. Likewise, the vegetable samples that showed activity were 
encapsulated in free systems of organic solvents. NP has shown to be a good alternative 
to load actives into nanoparticles. As good delivery systems, actives loaded into 
nanoparticles show stability, protection, controlled release and targeted. Different 
parameters during nanoprecipitation process can be modified to obtain a formulation with 
the desirable characteristics on the size, storage stability, active encapsulation and 
electrostatic charges.  
Based on the antimycobacterial activity revealed by previous studies, the first part 
of this work was focused on testing the effect of L. frutescens against M. tuberculosis to 
propose it as a co-adjuvant of the drugs used for the tuberculosis treatment, such as RIF. 
To obtain the methanol extract from leaves and roots of L. frutescens, an ultrasound 
method was developed, which allowed a good performance to be obtained in a short time 
(2 h). Two different fractionation methods were developed in order to obtain the hexane 
fraction of leaves and roots, the percentage of yield obtained with both methods was close. 
However, method 2 was selected to continue with the following partitions because it is 
faster and easier to execute. The chromatographic profiles of the extracts and fractions 
were obtained through HPLC, these results reveal that there is the same number of peaks 
between the extract (leaves or roots) and the fractions obtained from it; in roots there is 
higher number of peaks than leaves. 
The evaluation of the activity against M. tuberculosis of the extracts and fractions 
of L. frutescens revealed that in roots are more activity than in leaves, specifically, EMR, 
FHR and RF1 (MIC = 100, 40 and 40 ȝg/mL, respectively). Biodegradable NP of RIF and 
vegetable samples (EMR, FHR and RF1) of L. frutescens were prepared by 
nanoprecipitation. NP showed a size from 140 to 190 nm, with homogeneous distributions 
and negative zeta potential. RIF had a MIC of 0.20 ȝg/mL, but when RIF is encapsulated 
in NP-PLGA-PVAL, it enhanced its activity (0.10 ȝg/mL) against M. tuberculosis. On the 
other hand, the hexane fractions in NP had more activity than free. The most active 
formulation was NP-PLGA-FHR and NP-PLGA-RF1 with a MIC of 80 ȝg/mL for both. 
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The combination of FHR and RF! with RIF decreases the MIC value in both cases, 
demonstrating a better effect. Finally, the toxicity of the best samples was proved, at the 
active concentrations against M. tuberculosis RIF and NP-RIF did not present hemolysis. 
Whereas, RF1 and NP-RF1 showed hemolysis. However, when RF1 is combined with 
RIF, the concentrations decreased from 40 to 10 ȝg/mL for RF1 and from 80 to 20 ȝg/mL 
for RF1 loaded NP, and at these concentrations there is no presence of hemolysis. This 
suggested that the encapsulation of RF1 in NP favored the reduction of its toxicity. 
Therefore, an alternative to make use of the hexane fraction from roots of L. frutescens 
with potential activity against M. tuberculosis, at concentrations below the hemolytic 
effect, is to combine it with conventional antituberculosis drugs such as RIF, and thus, to 
enhance the activity. 
 
Because of L. frutescens has been less studied for its antioxidant capacity, the 
second part of this work was focused on the antioxidant effect of the previously obtained 
extracts and fractions. The extracts and fractions of the L. frutescens plant showed a 
certain degree of protection, avoiding the lysis of RBC caused by the induced oxidation 
of AAPH reagent. FHH, EMR, FHR, RF1, RF2 and RF4 presented their maximum 
antioxidant activity at low concentrations and, subsequently, decreased when they were 
tested at higher concentrations due to a hemolysis effect. EMH, HF1, HF2, HF3, HF4, 
HF5 and RF5 were samples with antioxidant activity from 25 to 200 ȝg/mL and without 
hemolytic effect, being selected the fraction HF4 for the studies that proceeded. 
Suspensions of HF4 loaded NP were obtained by the nanoprecipitation technique, NP had 
a particle size around 200 nm with a homogeneous distribution. A chromatographic 
method was partially validated to be used for the quantification of the peaks-components 
present in HF4, from which the encapsulation of four peaks in NP was determined, it 
revealed a favorable incorporation of the L. frutescens fraction. Finally, when HF4 was 
incorporated in NP the antioxidant activity was conserved. For this reason, the 
incorporation of HF4 loaded NP is promising as an antioxidant agent because the 
encapsulation of the fraction is achieved, its properties are preserved, and it is non-toxic 
at the active concentrations. 
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An important part of the characterization of nanoparticulate systems is the 
determination of the percentage drug loading and encapsulation efficiency, for this raison 
a method of quantification by HPLC was developed and validated using the peaks-
components of the plant as internal markers. Therefore, in this work we proposed a new 
strategy for the quantification of extracts or fractions of L. frutescens.   
 
In the last part of the study, to make use of a sustained release system different of 
NP was proposed. Studies with NE were carried out testing the effect of sonication time, 
surfactant concentration and oil/water ratio on particle size, PDI, zeta potential and 
stability. The optimal formulation was selected for the encapsulation of RIF and the active 
fraction RF1 against M. tuberculosis. NE had a diameter around 180 nm, homogeneous 
size distribution, negatively charged and stable for 77 days. Both formulations showed 
high encapsulation efficiency. The anti-M. tuberculosis activity showed inhibition at the 
same concentrations including blank NE, this behavior can be attributed to the presence 
of oleic acid as oil phase. Thus, the optimal characterized and tested NE can be promising 
in the inhibition of M. tuberculosis. 
 
With the results obtained in our work, the knowledge about the L. frutescens plant 
is extended, either by its activity against M. tuberculosis or by its antioxidant activity. 
Likewise, it is revealed that NP or NE are a promising alternative to load extracts or 
fractions of the plant, converting them into a viable formulation for its administration. 
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IX. PERSPECTIVES 
 
Based on the results and conclusions obtained in this Doctoral Thesis, the perspectives 
are oriented in different directions. 
 
In the Chapter 1, the results related to RIF, L. frutescens, NP and its activity against 
M. tuberculosis were shown. For this first section, future research would be about in vitro 
release studies of the active formulations obtained in order to know the time of release of 
the actives to the environment in which they would be in the body and, also, to propose 
their release mechanisms. Because the target organ of the formulations are macrophages, 
in vitro studies on macrophages would be promising. Likewise, from the favorable results 
obtained on the combination of the drug RIF and the formulation of NP-PLGA-RF1, we 
propose to work with the tests to determine the synergism effect. On the other hand, it 
would be interesting to know about the distribution of the active formulations in an 
organism, for which we suggest to carry out in vivo biodistribution studies of RIF and RF1 
free and encapsulated into NP, individually and in combination. The final perspective to 
this chapter is to carry out the studies of isolation and identification of the compounds 
from the extracts and root fractions of L. frutescens that have the best activity against M. 
tuberculosis, encapsulation of the compounds in NP, the characterization of NP and 
studies of their effect on M. tuberculosis. 
 
In the Chapter 2, the results related to L. frutescens, NP and its antioxidant activity 
were presented, due to the promising results obtained with the antioxidant effect of the 
plant, future investigations would be studies of in vitro release of the active encapsulated 
into formulations in order to know the time of release towards the environment in which 
they would be in the organism, also, to propose its release mechanisms and in vivo 
biodistribution studies. 
 
Finally, in the Chapter 3, the results related to RIF, RF1, NE and their activity 
against M. tuberculosis were shown. Based on our research, it will be of great interest to 
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work on the formulation, determining the oil phase and aqueous phase that does not 
present activity in the microbiological studies. 
 
For all the formulations obtained in this thesis work, other in vitro and in vivo 
methods should be carried out to expand knowledge about toxicity. 
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